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1A. ABSTRACT
Transposons are mobile elements of 
genetic material that are able to move 
in the genomes of their host organisms 
using a special form of recombination 
called transposition that does not require 
extensive target sequence homology. 
Bacteriophage Mu was the fi rst transposon 
for which a cell-free in vitro transposition 
reaction was developed. Subsequently, the 
reaction has been refi ned and the minimal 
Mu in vitro reaction is useful in the 
generation of comprehensive libraries of 
mutant DNA molecules that can be used in 
a variety of applications. However, to date, 
the functional genetics applications of Mu 
in vitro technology have been subjected 
to either plasmids or genomic regions 
and entire genomes of viruses cloned on 
specifi c vectors. 
The present study expands the use 
of Mu in vitro transposition in functional 
genetics and genomics by describing 
novel methods applicable to the targeted 
transgenesis of mouse (Mus musculus) 
and the whole-genome analysis of 
bacteriophages. The methods described 
here are rapid, effi cient, and easily 
applicable to a wide variety of organisms, 
demonstrating the potential of the Mu 
in vitro transposition technology in the 
functional analysis of genes and genomes.
First, an easy-to-use, rapid strategy 
to generate construct for the targeted 
mutagenesis of mouse genes was 
developed. To test the strategy, a fragment 
of KCC2, a gene encoding a neuronal K+/
Cl- cotransporter was mutagenised. After 
a highly effi cient in vitro transpositional 
mutagenesis with a transposon containing 
a neomycin resistance marker gene 
fl anked by loxP sites, the gene fragments 
mutagenised were separated, cloned into 
a vector backbone, and subsequently 
transferred into bacterial cells. The desired 
constructs were screened with polymerase 
chain reaction using an effective three-
dimensional matrix system. In addition 
to traditional knock-out constructs, the 
method developed yields hypomorphic 
alleles that lead into reduced expression of 
the target gene in transgenic mice. These 
alleles have since been used in a follow-
up study. Moreover, a scheme is devised 
to rapidly produce conditional alleles from 
the constructs produced.
Next, an effi cient strategy for the 
whole-genome analysis of bacteriophages 
was developed based on the transpositional 
mutagenesis of uncloned, infective virus 
genomes and their subsequent transfer 
into susceptible host cells. Mutant 
viruses able to produce viable progeny 
were collected using the blue/white 
selection, autoradiography, or based on 
mobility in agarose gel electroforesis 
and their transposon integration sites 
were determined to map genomic regions 
nonessential to the viral life cycle. This 
method, applied here to three very different 
bacteriophages, PRD1, ΦYeO3-12, and 
PM2 infecting different host bacteria, 
does not require the target genome to be 
cloned and is directly applicable to all 
DNA and RNA viruses that have infective 
genomes. The method developed yielded 
valuable novel information on the three 
bacteriophages studied and whole-
genome data can be complemented with 
concomitant studies on individual genes. 
Moreover, end-modifi ed transposons 
constructed for this study can be used to 
manipulate genomes devoid of suitable 
restriction sites.
Abstract
2B. INTRODUCTION
1. TRANSPOSONS
Transposons (or transposable elements, 
TEs) are mobile elements of genetic 
material that can move from one site in 
a genome into another site or even into 
another genome by transposition, a special 
form of recombination that generally does 
not require extensive target sequence 
homology.
Transposable elements are almost 
universal: they have been found in the 
genomes of virtually all the organisms that 
have been studied in any detail including 
Bacteria (reviewed in Campbell, 2002), 
Archaea (reviewed in Brugger et al., 
2002), and eukaryotic kingdoms of Fungi 
(reviewed in Kempken and Kuck, 1998), 
(Green) Plants, and Animals (reviewed in 
Deininger and Roy-Engel, 2002). Some 
symbiotic obligate intracellular bacteria 
are known to lack TEs, apparently due 
to the evolutional pressure to genome 
streamlining (Andersson et al., 2002, 
Bordenstein and Reznikoff, 2005). 
1.1. Transposon classes
Transposons can be divided into two 
classes according to whether they have 
an RNA intermediate in their lifecycle or 
not. The terminology of these classes, that 
can be further divided into subclasses, has 
been confl icting and often confusing. 
1.1.1. Class I transposons
Class I transposons have an RNA 
intermediate in their life cycle. The 
genomic element is transcribed into an 
RNA copy by an RNA polymerase and 
converted back to DNA by a reverse 
transcriptase (RT). These retroelements 
can be further divided into two classes 
according to whether DNA or RNA is the 
actual substrate for recombination. 
Retrotransposons (or LTR 
retrotransposons, retroviral-like elements) 
have long terminal repeats (LTRs), directly 
repeated segments at their ends. In their 
life cycle, the RNA element is fi rst reverse-
transcribed into DNA and this DNA is 
then used as a substrate for transposition 
into the host genome. Their composition 
resembles animal retroviruses. Endogenous 
retroviruses residing in the genome and 
LTR retrotransposons are collectively 
referred to as LTR elements.
Retroposons (or non-LTR trans-
posons) are mobile elements in which 
the RNA form acts as the transposition 
substrate by attaching directly to a nick in 
the DNA sequence that serves as a primer 
to the reverse transcription reaction. The 
DNA strand transcribed is thus covalently 
linked into the target DNA (Luan et al., 
1993). 
1.1.2. Class II transposons (DNA 
transposons)
Class II transposons move in the genomes 
solely as discrete DNA elements with 
no RNA intermediates involved. Their 
movement is catalysed by one or several 
self-coded transposases that recognise 
specifi c end sequences at each end of the 
transposon. These terminal sequences are 
most commonly in inverse orientation 
(inverted repeats, IR). Class II elements are 
usually referred to as DNA transposons. In 
Bacteria, where class II elements of widely 
varied complexity are found, the simplest 
elements are called insertion sequences 
(ISs), whereas the term transposon 
traditionally refers to the more complex 
transposons (see chapter 1.2.1.).
Introduction
3In some, mostly eukaryotic genomes 
there are short (~100...500 bp), non-
autonomous elements that are present 
in high copy numbers. These miniature 
inverted-repeat transposable elements 
(MITEs) have conserved terminal repeats 
and target-site specifi city, but no coding 
potential (reviewed in Feschotte et al., 
2002). Because of their distinct properties 
they have sometimes been classifi ed 
as class III transposons (used in e.g. 
Yu et al., 2002)  However, it is evident 
that these elements originated from a 
subset of existing DNA transposons and 
thus are classifi ed as a subclass of class 
II transposons (Turcotte et al., 2001, 
Feschotte et al., 2002, Kidwell, 2002).
1.2. Transposons in different species
The common denominator in the discovery 
of transposable elements in model species – 
maize, bacteria, and fruit fl y – was that they 
were found by accident, as a by-product 
of studying other phenomena (Shapiro, 
1995). They were initially labelled “selfi sh 
DNA” with no evident benefi ts to the cell 
itself (Orgel and Crick, 1980, Doolittle and 
Sapienza, 1980, Doolittle et al., 1984). As 
the idea that TEs provide evolutionarily 
important fl uidity to the genomes has 
gained more ground (for example Blot, 
1994) and extensive sequencing projects 
have provided genomic data from a variety 
of species, the occurrence of transposons 
has been studied as part of whole-genome 
sequencing projects (for example Lander 
et al., 2001, Wood et al., 2002, Hillier et 
al., 2004) or as a separate analysis from 
whole-genome sequence data (for example 
Kim et al., 1998, Kaminker et al., 2002).  
Generally, small genomes have 
few TEs while in large genomes there is 
an abundance of mobile elements. The 
proportion of transposable elements in the 
genomes of different species is represented 
in Table 1.
1.2.1. Bacterial transposons
There is a remarkable structural variety 
in bacterial DNA transposons ranging 
from simple insertion sequences (IS) and 
composite transposons to more complex 
elements and bacteriophages that use 
transposition as a lifestyle (Figure 1). In 
addition, the study of bacterial genomes 
has revealed a new class of elements, 
retrons, that are potentially proliferating 
though RNA-mediated transposition (for a 
recent review see Lampson et al., 2005). 
1.2.1.1. Bacteriophage Mu and other 
transposable viruses
The most complex transposons identifi ed 
are bacteriophages that use transposition 
as a lifestyle. The temperate bacteriophage 
Mu (short for Mutator), isolated from the 
city sewage of Denver in Colorado, USA, 
was originally identifi ed on the basis of 
its ability to cause mutations in a variety 
of Gram-negative bacteria including 
Escherichia coli (Taylor, 1963). The 36.7-
kb Mu genome (Figure 1D) consists of two 
transposase genes and terminal inverted 
end sequences in addition to 53 genes 
involved in other functions of the Mu life 
cycle (Howe, 1987, Morgan et al., 2002). 
Bacteriophage Mu is exceptional in 
that it utilises DNA transposition in two 
different ways (see chapter 2.1). During 
the initial infection it integrates into the 
bacterial host genome by conservative 
transposition (Harshey, 1984). However, 
during lytic growth Mu replicates itself by 
multiple rounds of replicative transposition 
(Chaconas et al., 1981) (see chapter 2.2). 
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D
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%
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Escherichia coli (eubacterium) 4.6 2.0 2.0 Blattner et al., 1997  
Burkholderia mallei (eubacterium) 5.8 3.1 3.1 Nierman et al., 2004  
Methanobacterium
thermoautotropicum
(archaeon) 1.8 0 0 Smith et al., 1997 
Sulfolobus solfataricus (archaeon) 3.0 10.5 10.5 She et al., 2001  
Saccharomyces cerevisiae budding yeast 12 3.1 0 Kim et al., 1998 
Schizosaccharomyces 
pombe
fission yeast 14 0.35 0 Wood et al., 2002 
Aspergillus oryzae (filamentous
fungus)
36 1.4 0.7 Galagan et al., 2005  
Magnaporthe grisea (fungal plant 
pathogen)
40 9.7 2.0 Dean et al., 2005  
Arabidopsis thaliana mustard weed 125 10 3 Arabidopsis Genome 
Initiative., 2000, Haas et 
al., 2005 
Oryza sativa rice 430 13* 7* Yu et al., 2005 
Aegilops tauschii  Tausch's 
goatgrass
4000 >90* 13* Li et al., 2004  
Caenorhabditis elegans (nematode 
worm)
100 6.5 5.3 Lander et al., 2001  
Drosophila melanogaster fruit fly 121 3.9† 0.3† Biemont and Vieira, 2005  
Anopheles gambiae malaria 
mosquito 
280 16† ? Holt et al., 2002 
Fugu rubripes torafugu
(bufferfish)
370 <5 ? Aparicio et al., 2002  
Gallus gallus chicken 1100 9 0.8 Hillier et al., 2004  
Canis familiaris dog 2400 35 2.0 Lindblad-Toh et al., 2005
Mus musculus mouse 2500 39 0.9 Waterston et al., 2002, 
Lindblad-Toh et al., 2005 
Homo sapiens man 2900 46 3.0 Lander et al., 2001,  
Lindblad-Toh et al., 2005 
* estimate 
† euchromatin only 
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5Figure 1. Examples of different bacterial transposons (not to scale). A) Insertion sequences (IS) 
typically only have transposase gene(s) (Tnp). Inverted repeats (IR, black triangles) are essential 
to mobility (drawn according to Reznikoff, 2003). B) Composite transposons consist of two ISs 
separated by one or several genes unrelated to transposition but often conferring a selective ad-
vantage to the host. In Tn5 only one of the ISs encodes functional transposase. KanR, BleR, StrR = 
genes encoding resistance to kanamycin, bleomycin, and streptomycin, respectively (Reznikoff, 
2003). C) Complex transposons have more complicated structure consisting of several genes 
involved in transposition (TnsA-E in Tn7) and no ISs at their ends. Tn7 has an integron contain-
ing several antibiotic resistance cassettes (Peters and Craig, 2001). D) Bacteriophage Mu has 
two genes involved in transposition (black). Other genes (white) are related to non-transposition 
functions. IAS (Internal Activator Sequence), ~100 bp-long enhancer region needed for effi cient 
transposition in vivo is situated ~1000 bp from the left end (Howe, 1987, Morgan et al., 2002). 
Regions involved in transposition at each end are magnifi ed and MuA transposase protein bind-
ing sites and their orientations are depicted with black arrows. Numbers indicate distance (in bp) 
from proximal transposon end (Craigie et al., 1984).
The Mu transposition, extensively studied 
for years (for reviews see Mizuuchi 
and Craigie, 1986, Mizuuchi, 1992, 
Chaconas et al., 1996, Chaconas and 
Harshey, 2002), was the fi rst transposition 
reaction for which a cell-free in vitro 
system was developed (Mizuuchi, 1983). 
Bacteriophage Mu transposition has been 
used extensively both in vivo and in vitro 
in molecular biology applications (see 
chapter 3).
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6Apart from Mu, only a few other 
transposable bacteriophages have been 
isolated. Bacteriophage D108, a closely 
related virus of E. coli, was discovered 
in Japan in 1971 (Mise, 1971). A large 
number of transposable bacteriophages 
of Pseudomonas genus were isolated in 
the former Soviet Union in the 1970s and 
80s (Akhverdian et al., 1984 – reviewed 
in DuBow, 1987). Moreover, bacterial 
genome-wide sequencing projects have 
revealed Mu-like prophages at least in 
Haemophilus, Neisseria, and Deinococcus 
(Morgan et al., 2002). 
1.2.1.2. Transposon content in bacterial 
genomes
There are large variations in the transposon 
content between related bacterial species 
and even between different strains of 
the same species. In the 4.6-Mb genome 
of Escherichia coli strain K-12 mobile 
elements, including transposable 
elements, bacteriophages, and plasmids, 
comprise 2.0 %. At least 42 IS copies were 
identifi ed in the genome representing 
fi ve different families. The distribution 
of IS elements was notably non-random 
as two multicomponent clusters were 
detected (Blattner et al., 1997). There are 
notable differences in the occurrence and 
abundance of ISs between different E. coli 
strains (Sawyer et al., 1987). 
No insertion sequences were detected 
in the 4.2-Mb genome of Gram-positive 
Bacillus subtilis, whereas there were 93 
and 10 such elements in closely related 
B. halodurans and B. licheniformis, 
respectively. These differences indicate 
that horizontal transfer of ISs might play 
an important role in the bacterial speciation 
(Kunst et al., 1997, Takami et al., 2000, 
Rey et al., 2004).
Some symbiotic obligate intracellular 
bacteria that cannot survive outside 
their host cells and transmit themselves 
vertically from mother to offspring are 
known to lack TEs, apparently because 
of their constrained access to novel gene 
pools and the evolutional pressure to 
genome streamlining (Andersson et al., 
2002, Bordenstein and Reznikoff, 2005). 
Nevertheless, even parasitic obligate 
intracellular bacteria that have the ability 
to switch hosts and transmit themselves 
horizontally seem to have transposable 
elements in their genomes (Nierman et 
al., 2004, Bordenstein and Reznikoff, 
2005). The causative agent of glanders, 
Burkholderia mallei is a highly evolved 
obligate parasite of horses. In its 5.8 
Mb genome ISs comprise 3.1 % in 171 
complete or partial elements (Nierman et 
al., 2004). 
1.3. Transposon-like phenomena in 
cells
Apart from transposable elements 
themselves, other cellular phenomena 
that use mechanisms closely related to 
transposition range from parasitic viruses 
to functions essential to the host cells and 
organisms.
1.3.1. Retroviruses
Retroviruses have their genome in the 
form of RNA in viral particles. Following 
infection they are able to reverse-transcribe 
their genome into dsDNA and insert it 
into the host genome. DNA is processed 
and joined into the genome by a specifi c 
enzyme, the integrase, that resembles 
transposases of DNA transposons (Polard 
and Chandler, 1995). Mechanistically 
retroviral integration is very similar to 
replicative transposition (reviewed in 
Craig, 1995, see chapter 2). It has been 
proposed that retroviruses originated from 
an LTR retrotransposon that acquired the 
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binding protein responsible for virus 
transmission (Boeke and Stoye, 1997, 
Eickbush and Malik, 2002).
1.3.2. V(D)J recombination
In most vertebrates the diversity of 
immune system is mediated by V(D)J 
recombination, the rearrangement of gene 
segments during the maturation of B and 
T cell lymphocytes. The parallels between 
V(D)J recombination and transposition 
are remarkable (Lewis and Wu, 1997, 
Agrawal et al., 1998, Gellert, 2002, Brandt 
and Roth, 2004). V(D)J recombination is 
mediated by RAG1 and RAG2 proteins 
that break both strands of DNA precisely 
at the border between protein-coding 
and neighbouring recombination signal 
segments. In contrast to transposition, 
the ends of remaining fl anking DNA are 
processed and joined in V(D)J, whereas 
the ends that contain the recombination 
signal segments are simply circularised 
and released (reviewed in Brandt and Roth, 
2004). RAG1 apparently belongs to the 
DDE transposase family that have a core 
of three catalytic acidic residues essential 
to DNA cleavage and strand transfer 
(Haren et al., 1999b, Landree et al., 1999, 
Zhou et al., 2004) and RAG system has 
the ability to perform transposition in vitro 
(Agrawal et al., 1998, Hiom et al., 1998). 
Intronless RAG genes lie side-to-side in 
the genome, resembling more genes of 
bacteria than those of higher eukaryotes 
(Oettinger et al., 1990, Thompson, 1995). 
Moreover, housefl y DNA transposon 
Hermes processes the DNA ends fl anking 
the element analogously to V(D)J (Zhou 
et al., 2004), reinforcing the view that 
V(D)J recombination arose when an 
ancient transposon was harnessed by 
the lymphocytes (Lewis and Wu, 1997, 
Agrawal et al., 1998, Gellert, 2002, 
Oettinger, 2004, Zhou et al., 2004).
1.3.3. Telomere-associated 
retrotransposons
The linear chromosomes of most 
eukaryotic cells are protected at their 
ends by telomeres, simple repeats that 
are periodically extended by the enzyme 
telomerase that synthesises new repeat 
sequence by reverse transcription 
(reviewed in Pardue and DeBaryshe, 1999). 
Because of the similarity in their catalytic 
mechanisms and the phylogenetic relation 
of their sequences (Lingner et al., 1997), 
it has been suggested that telomerase 
enzymes might have evolved by cellular 
recruitment of a retroposon RT gene 
(Zimmerly et al., 1995, Eickbush, 1997). 
This view is reinforced by the fact that 
in Drosophila telomeres are maintained 
by specialised retroposons instead of 
the telomerase enzyme (Biessmann et 
al., 1992, Levis et al., 1993, Abad et al., 
2004).
1.4. Why to study transposons?
Transposons are ubiquitous components 
of virtually all cells. How transposition 
occurs and what factors determine its 
frequency is of considerable interest as 
transposons can play a profound role 
in genome evolution and in a variety of 
genetic diseases. Transposition offers a 
potent mechanism to introduce a variety of 
mutations and alter the expression of genes 
to analyse their functions. Moreover, other 
important phenomena in the cells exploit 
mechanisms similar to transposition. 
Consequently, understanding mechanisms 
and control of transposition can help to 
defi ne processes involved, for instance, 
in retrovirus infections or vertebrate 
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can be utilised in molecular biology to 
carry out such basic tasks as cloning and 
sequencing.
2. MECHANISMS OF DNA-MEDIATED 
TRANSPOSITION
Most DNA-mediated transposition 
reactions described, including LTR 
retrotransposition and retroviral 
integration, occur by similar DNA breakage 
and joining reactions, demonstrating 
remarkable unity (Figure 2). Transposition 
proceeds by endonucleolytic cleavage of 
the phosphodiester bonds at the exact ends 
of the TE and transfer of these ends into 
Figure 2. Unity in transposition reactions. Mobile elements are depicted by bold black double 
line, target DNA by dark grey double line, and DNA synthesised during transposition by light 
grey. Small arrows indicate DNA cleavage sites. See text for details. (Drawn according to Craig, 
1995)
a target DNA molecule. Breakage events 
precisely expose 3’ tips of TEs that are 
joined to the exposed 5’ ends of cleaved 
target DNA. These functions are catalysed 
by one or several TE-encoded transposase 
proteins. The last steps of a transposition 
reaction, repair of remaining gaps and 
possible replication of the transposon, 
are carried out by the host replication 
mechanism (reviewed in Craig, 1995).
2.1. Conservative vs. replicative 
transposition
According to whether a TE is copied in 
the process, transposition reactions can be 
divided into conservative and replicative 
events (Figure 2).
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replicative or cut-and-paste) transposition, 
a TE is excised from its previous location 
and moved into a new site. Even though the 
element is not duplicated in the process, 
TEs that employ conservative transposition 
are still capable of propagating in the 
genome by moving from replicated areas 
of the genome into unreplicated regions 
during cell division (Brookfi eld, 1995). In 
the conservative replication pathway the 
TE is cleaved at both its 3’ and 5’ ends, 
releasing the element that is then joined 
to the target DNA molecule (Craig, 1995, 
Haren et al., 1999a). This is the most 
common mode of transposition, observed 
in a wide variety of elements including 
bacterial Tn7 (reviewed in Craig, 2002), 
IS10 (Kleckner et al., 1996), and Tn5 & 
IS50 (Goryshin and Reznikoff, 1998), as 
well as eukaryotic DNA transposons of the 
mariner/Tc family (reviewed in Plasterk et 
al., 1999) and the Drosophila P element 
(Engels et al., 1990). In each case the 
transposase only cleaves one DNA strand, 
releasing the 3’ ends of the element. Several 
different strategies have been adopted for 
the cleavage of the other strand including a 
passage through a hairpin intermediate, the 
use of two endonucleases, or transposition 
via a circular intermediate (reviewed in 
Turlan and Chandler, 2000).
In replicative transposition a copy 
of the TE remains in the original site 
while another clone of the transposon is 
copied into a new location. This type of 
transposition requires that the element is 
replicated in the transposition process. In 
replicative transposition the transposon 
is only cleaved at its 3’ ends. If the 
transposition is intermolecular, replication 
of the element generates cointegrates in 
which donor and target replicons are joined 
but separated by a directly repeated copy 
of the TE at each junction. Resolution of 
this cointegrate by recombination between 
the two elements regenerates the donor 
and target molecules each carrying a 
copy of the TE (Craig, 1995, Haren et al., 
1999a). A few bacterial systems including 
bacteriophage Mu (Chaconas et al., 1981), 
the IS6 family (Mahillon and Chandler, 
1998), and likely also the members of the 
Tn3 transposon family (Craig, 2002) use 
replicative transposition. Bacterial IS903 
uses mostly the conservative transposition 
pathway but products of replicative 
transposition occur at a low frequency 
(<0.1 %). Apparently these are the result of 
a delay in the transposon 5’ end cleavage, 
further implicating the similarity of 
conservative and replicative transposition 
pathways (Tavakoli and Derbyshire, 2001; 
also see Figure 2).
Some groups of DNA transposons 
use mechanisms fundamentally different 
from both conservative and replicative 
transposition. The bacterial IS91 (Mendiola 
et al., 1994)  and eukaryotic Helitrons 
(Kapitonov and Jurka, 2001) employ 
a rolling-circle mechanism of trans-
position and resemble more prokaryotic 
plasmids than other transposable elements 
(Mendiola and de la Cruz, 1992, Garcillán-
Barcia et al., 2002).
2.2. Replicative transposition of 
bacteriophage Mu
The replicative transposition of 
bacteriophage Mu is well characterised 
on the biochemical level (see Mizuuchi, 
1992, Chaconas et al., 1996, Chaconas 
and Harshey, 2002 for reviews). The 
recombination mechanism used by Mu is 
similar to that of many other transposable 
elements (Craig, 1995).  There are also 
mechanistic similarities to retroviral 
integration (Fujiwara and Mizuuchi, 1988, 
Mizuuchi, 1992, Craig, 1995, Andrake 
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and Skalka, 1996) and the early stages of 
V(D)J recombination (Craig, 1996, van 
Gent et al., 1996, Roth and Craig, 1998). 
2.2.1. Transposition requirements in 
vivo
A nucleoprotein complex that consists 
of specifi c DNA sites at the ends of the 
bacteriophage and a tetramer of viral-
encoded transposase protein MuA is 
essential to the Mu transposition reaction. 
This nucleoprotein complex is called 
a transpososome (Surette et al., 1987, 
Baker and Mizuuchi, 1992, Yuan et al., 
2005). Another Mu-encoded protein, 
MuB, is also directly involved in Mu 
transposition (Faelen et al., 1978). In 
addition, several host-encoded factors 
assist the transposition reaction. In E. coli, 
the most important host accessory proteins 
are DNA binding proteins IHF (Integration 
Host Factor) (Surette and Chaconas, 1989) 
and histone-like protein HU (Craigie et al., 
1985). Moreover, molecular chaperone 
ClpX is essential in the DNA-transposase 
complex disassembly (Levchenko et al., 
1995, Kruklitis et al., 1996). 
Of the enzymatic cofactors, divalent 
cations are required in the assembly of the 
nucleoprotein complex and later in DNA 
cleavage and strand transfer reactions. 
Assembly of the nucleoprotein complex 
is possible using Ca2+, Mg2+, or Mn2+ but 
calcium does not support the subsequent 
DNA cleavage step. Mg2+ is likely the 
biologically relevant cation (Craigie and 
Mizuuchi, 1987, Surette et al., 1987, 
Baker et al., 1991, Mizuuchi et al., 1992, 
Savilahti et al., 1995). ATP is only needed 
for the stimulatory action of MuB protein 
(Craigie and Mizuuchi, 1987).   
At the ends of the 37-kb Mu genome 
there are six binding sites for the specifi c 
DNA binding protein MuA, three at the 
left end (named L1-L3 inwards from the 
terminus) and three at the right end (R1-
R3) (Figure 1D). These sites share a 22-
bp consensus sequence (Craigie et al., 
1984). Sites L1, R1, and R2 are essential 
in the formation of the transpososome 
complex (Lavoie et al., 1991), and L1 has 
a central role in the catalytic commitment 
of the transpososome (Kobryn et al., 
2002). Another enhancer site, internal 
activation sequence (IAS – see Figure 1D) 
is also essential for an effi cient in vivo 
transposition (Mizuuchi and Mizuuchi, 
1989). MuA binds Mu ends and the IAS 
with different subdomains (Leung et al., 
1989). In order to the transposition reaction 
to occur in normal cellular conditions, Mu 
ends and the IAS are required to be in the 
same molecule in a proper orientation 
relative to each other. Moreover, the Mu 
transposon DNA has to be negatively 
supercoiled (Craigie et al., 1985).
The MuA transposase is a 663-amino 
acid (75 kDa) protein (Harshey et al., 
1985, Yuan et al., 2005) divided into three 
major globular domains (Nakayama et 
al., 1987). The N-terminal domain I binds 
transposon DNA: Iα interacts with the 
IAS enhancer whereas Iβ and Iγ recognise 
and bind transposon ends (Nakayama et 
al., 1987, Leung et al., 1989, Kim and 
Harshey, 1995). The central domain II is the 
catalytic core: IIα contains the DDE motif, 
a triad of catalytic acidic residues essential 
to DNA cleavage and strand transfer 
(Baker and Luo, 1994, Krementsova et 
al., 1998) that is conserved in transposases 
of prokaryotic and eukaryotic mobile 
elements as well as retroviral integrases 
(Rice and Mizuuchi, 1995, reviewed 
in Haren et al., 1999a, Chandler and 
Mahillon, 2002). The C-terminal domain 
III can be divided into two regions: 
domain IIIα is thought to act together with 
IIβ in the Mu-host junction interactions, 
assembly of the transpososome complex 
and structural transitions of that complex 
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(Krementsova et al., 1998, Naigamwalla 
et al., 1998, Namgoong et al., 1998). 
Domain IIIβ interacts with MuB and CplX 
proteins (Baker et al., 1991, Levchenko et 
al., 1997).
2.2.2. Reaction intermediates
In the Mu transposition reaction the 
transpososome nucleoprotein complex 
evolves through several intermediate steps 
(Figure 3). Even though transposition is 
traditionally depicted as a linear pathway, 
several steps such as donor DNA cleavage, 
MuB target binding, and MuB-mediated 
target DNA entry can in reality occur 
in different orders or simultaneously, 
forming a network of reactions rather than 
an orderly linear pathway (Baker et al., 
1991, Naigamwalla and Chaconas, 1997, 
Yamauchi and Baker, 1998).
MuA binds the Mu ends initially as 
catalytically inactive monomers (Craigie 
et al., 1984, Kuo et al., 1991, Baker and 
Mizuuchi, 1992). At an early stage, an 
interaction of the Mu right end with IAS 
enhancer results in a two-site complex 
(enhancer - right end, ER) required for the 
HU-assisted capture of left end (Pathania et 
al., 2003)  forming the three-site synaptic 
complex (left end - enhancer - right end, 
LER) (Watson and Chaconas, 1996). MuA 
monomers are then transformed into the 
active MuA tetramer, forming the stable 
synaptic complex (SSC) (Mizuuchi et al., 
1992), also called type 0 transpososome 
(Chaconas et al., 1996).
In the SSC, L1 and R1-bound MuA 
monomers catalyse the cleavage of 3’ 
transposon ends in trans: reaction in one end 
of DNA is catalysed by the MuA monomer 
bound to the other end (Savilahti and 
Mizuuchi, 1996, Namgoong and Harshey, 
1998, Williams et al., 1999), forming the 
cleaved donor complex (CDC) (Craigie 
and Mizuuchi, 1987), also called type 1 
transpososome (Surette et al., 1987).
The next stage is the strand transfer 
reaction. MuB, an ATP-dependent DNA 
binding protein (Maxwell et al., 1987) that 
forms large polymers on DNA (Greene and 
Mizuuchi, 2002a, Greene and Mizuuchi, 
2002b), stimulates the strand transfer by 
recruiting a target molecule and delivering 
it to the transpososome (Baker et al., 
1991, Yamauchi and Baker, 1998). MuA 
cleaves the target DNA in a staggered 
manner, generating two target ends with 
5 bp 5’ overhangs. Free transposon 3’-OH 
groups are joined into these target 5’ ends, 
converting CDC into the strand transfer 
complex (STC) or type 2 transpososome 
(Craigie and Mizuuchi, 1985, Surette et 
al., 1987).
Figure 3. The replicative pathway of Mu transposition. L = Mu left end, R = Mu right end, E = 
IAS enhancer, Me2+ = divalent cation. MuA transposase monomers are depicted as black circles, 
target DNA as grey line. See text for details. (Drawn according to Pathania et al., 2003)
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STC disassembly starts with the 
activity of ClpX protein that alters the 
conformation of DNA-bound MuA and 
converts the STC into STC2 (Kruklitis 
et al., 1996) or type 3 transpososome 
(Chaconas and Harshey, 2002). MuA, 
still present in this complex, is removed 
through the action of other host proteins 
(Kruklitis et al., 1996). Host-encoded 
factors then initiate DNA replication, 
carried out by the replication machinery of 
the cell, including DnaB helicase, DnaC, 
and polymerase III holoenzyme (Kruklitis 
and Nakai, 1994, Nakai and Kruklitis, 
1995). The host replication machinery also 
repairs the single-stranded gaps produced 
by transposition. This process creates a 5-
bp target site duplication, a hallmark of the 
Mu transposition (Allet, 1979). 
Much less is known about the 
conservative transposition of Mu 
into the host genome following 
infection. Apparently the mechanism 
of transpososome assembly is different 
from replicative transposition, with less 
emphasis on DNA topology (Sokolsky 
and Baker, 2003).
2.2.3. Control of transposition
Uncontrolled proliferation of any 
transposable element would be deleterious 
to the host cell and thus very likely to 
the element itself as well. Moreover, 
an intramolecular transposition would 
most likely render the element inactive, 
thus destroying it. Therefore all TEs 
have to be able to restrict and control 
their transposition (Plasterk, 1995). 
Bacteriophage Mu codes for a repressor 
protein that negatively regulates early 
transcription including transposase genes. 
In addition, the repressor also directly 
inhibits transposition by binding into Mu 
operator sequences that overlap the IAS 
(Craigie et al., 1984), thus preventing the 
transpososome formation (Mizuuchi and 
Mizuuchi, 1989).
The requirements for target DNA are 
almost minimal in the Mu transposition 
reaction. Even though the target site 
selection is non-random (Castilho and 
Casadaban, 1991, Manna et al., 2001), 
there is no consensus sequence. Rather, 
some sites are statistically preferred 
(5’ C-Py-G/C-Pu-G 3’) (Mizuuchi and 
Mizuuchi, 1993, Butterfi eld et al., 2002, 
Haapa-Paananen et al., 2002). In regional 
level there is a preference associated with 
DNA sequences that have high affi nity to 
MuB protein, which demonstrates a weak 
but recognisable binding site preference 
(Mizuuchi and Mizuuchi, 1993, Greene 
and Mizuuchi, 2002a). Finally, non-Mu 
end sequences are strongly preferred as 
targets through a phenomenon called 
target (or transposon) immunity, in which 
one Mu sequence exerts an inhibitory 
effect on the probability of a second Mu 
inserting in nearby sequence (Adzuma 
and Mizuuchi, 1988, Manna and Higgins, 
1999). This is caused by MuB protein 
that binds DNA in the presence of ATP. 
MuA that specifi cally binds Mu end DNA 
can catalyse the dissociation of MuB 
from DNA in a process that requires ATP 
hydrolysis (Adzuma and Mizuuchi, 1988, 
Adzuma and Mizuuchi, 1989, Greene 
and Mizuuchi, 2002c). Contrastingly, in 
the transpososome complex, MuB-bound 
DNA is the preferred transposition target 
because MuB stimulates the recombinase 
activities of MuA (Baker et al., 1991, 
Yamauchi and Baker, 1998). Target 
immunity confers a gradually decaying 
immunity up to 25 kb from the transposon 
ends. This phenomenon probably 
evolved as a mechanism to prevent 
the bacteriophage from intramolecular 
transposition into itself (Adzuma and 
Mizuuchi, 1988, Adzuma and Mizuuchi, 
1989, Manna and Higgins, 1999).
Introduction
13
2.3. Mu transposition reactions in vitro
Bacteriophage Mu was the fi rst transposon 
for which a cell-free in vitro transposition 
reaction was developed. The original 
reaction used conditions suitable for in 
vitro DNA replication, a supercoiled 
donor plasmid carrying Mu end DNAs 
in proper orientation and E. coli cell 
extracts that contained MuA and MuB 
proteins (Mizuuchi, 1983). After that 
initial experiment Mu transposition has 
been studied extensively and transposition 
requirements for an in vitro reaction have 
been defi ned and minimised.
The topological constraints on 
transposon donor can be relaxed by adding 
dimethyl sulfoxide (DMSO) to the reaction, 
enabling the use of linear donors (Craigie 
and Mizuuchi, 1986). Moreover, DMSO 
makes IAS enhancer and HU protein 
obsolete. IHF, normally involved in IAS 
binding, is not required in these conditions 
(Mizuuchi and Mizuuchi, 1989).
The initial stages of transposition 
until CDC can be bypassed altogether 
by using pre-cut donor molecules. In 
this type of reaction the innermost MuA 
binding sites (L3 and R3) are not required; 
in fact, the most effi cient transposition is 
achieved using donors with two minimal 
right end (R1 & R2) sequences in inverted 
orientation (Craigie and Mizuuchi, 1987, 
Namgoong et al., 1994). In reduced salt 
concentrations glycerol can be used instead 
of DMSO to stimulate strand transfer 
reactions (Mizuuchi and Mizuuchi, 1989).
In relaxed in vitro conditions the MuB 
protein is not necessary for the reaction 
(Baker et al., 1991, Savilahti et al., 1995), 
even though MuB has been shown to 
stimulate the cleavage and strand transfer 
reactions also in altered (DMSO, glycerol) 
conditions (Lee and Harshey, 2001, Lee 
and Harshey, 2003). Without MuB, the 
reaction loses its target immunity (Baker 
et al., 1991). 
Taken together, the MuA transposase, 
pre-cleaved donor DNA with (R1,R2) 
Mu ends, and target DNA are the only 
macromolecular components required 
for the minimal Mu in vitro transposition 
reaction (Savilahti et al., 1995, Haapa et 
al., 1999a). It is possible to insert marker 
sequences of variable length between the 
two Mu ends (Haapa et al., 1999a). In 
addition, the Mu ends themselves can also 
be modifi ed moderately (Taira et al., 1999, 
Laurent et al., 2000, Goldhaber-Gordon 
et al., 2002a, Goldhaber-Gordon et al., 
2002b, Poussu et al., 2005). Minimal 
reaction conditions have been used in a 
variety of Mu in vitro applications (see 
chapter 3.4).
3. TRANSPOSONS AS TOOLS IN 
MOLECULAR BIOLOGY
The ability of transposons to move discrete 
segments of DNA to new locations where 
they disrupt target DNA, effectively 
combining the activities of a restriction 
endonuclease and a ligase, make them 
valuable tools in molecular biology (Berg 
and Berg, 1995). Apart from obvious loss-
of-function mutations associated with 
transposon insertion, TEs can also infl ict 
chromosomal rearrangements – deletions, 
duplications, inversions – by homologous 
recombination between two repeats. These 
rearrangements can be very complex, 
especially if several intertwined elements, 
possibly located in different DNA 
molecules, are involved (for a review see 
Gray, 2000).
The actual transposition reaction 
can occur either in vivo, within the cells, 
or in vitro, i.e. in the test tube. A wide 
range of different TEs and transposases 
from various organisms has been used 
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in vivo and for an increasing number of 
transposons an effi cient in vitro reaction 
has also been developed (reviewed in 
Boeke, 2002). 
3.1. In vivo vs. in vitro
In the fi rst generation of transposition 
applications the reactions were carried 
out in vivo, within the cells. In vivo trans-
position requires either the use of an 
endogenous transposon residing in the 
host genome or that the main reaction 
components, the transposon and the 
transposase protein, are introduced into 
the host cell. Typically, the transposon is 
in a suicide vector that does not proliferate 
in the host cell (for example Gonzales 
et al., 1996, Lee and Henk, 1996). 
The transposase is usually expressed 
in subsequent generations resulting in 
potential genetic instability (Kleckner, 
1990, Goryshin et al., 2000). Moreover, 
the use of heterologous transposons 
derived from another organism is not 
always possible due to limitations in the 
host range of transposons. To circumvent 
this problem, E. coli can be used as a 
surrogate host where transposition is 
carried out and the resultant products 
are subsequently transferred back to the 
original host (reviewed in Hamer et al., 
2001). Despite its limitations in vivo 
transposition is a practical mutagenesis 
method that is frequently used, for 
example, in the functional genomics of 
bacteria (recent examples include Banh 
et al., 2005, McCarren and Brahamsha, 
2005, Glass et al., 2006).
Performing transposition reactions in 
vitro in a cell-free system offers several 
advantages over traditional in vivo systems. 
Host-range limitations can be avoided if 
transposition reactions are carried out in 
vitro and the reaction products transformed 
into host cells. The reactions can be carried 
out using fewer components, allowing 
better control over reactions and a wider 
range of reaction conditions. Thus, in 
vitro reactions are generally much more 
effi cient (Goryshin and Reznikoff, 1998, 
Haapa et al., 1999a, Biery et al., 2000). If 
components that are critical for a specifi c 
step of the process are left out, the reaction 
can be arrested at a suitable stage to study 
(for example Craigie and Mizuuchi, 1985, 
Mizuuchi et al., 1992) or otherwise exploit 
reaction intermediates (Goryshin et al., 
2000, Lamberg et al., 2002). Moreover, 
transposable elements often display 
target site preferences in vivo; transposon 
integration can be markedly more random 
using fewer reaction components in 
vitro (Boeke and Devine, 1998, Biery 
et al., 2000, Boeke, 2002). Finally, in 
vitro reactions also allow the subsequent 
manipulation of transposons and reaction 
products (for example Taira et al., 1999, 
Laurent et al., 2000, Kekarainen et al., 
2002, Poussu et al., 2004, Poussu et 
al., 2005). Simple in vitro transposition 
systems have been developed for several 
transposons including bacteriophage Mu 
(Haapa et al., 1999a), Tn5 (Goryshin and 
Reznikoff, 1998), Tn10 (Chalmers and 
Kleckner, 1994), Tn552 (Griffi n et al., 
1999), Tn7 (Biery et al., 2000), mariner 
(Tosi and Beverley, 2000), and Ty1 
(Devine and Boeke, 1994).
One disadvantage of in vitro 
transposition is that transposition does not 
occur in the natural environment of genes. 
In order to have biological selection, in vitro 
transposition products have to be delivered 
into the host cells. Generally, plasmids 
or small viral genomes mutagenised can 
be transferred into cells, even though 
some transposition products can be lost 
in transfer. However, the mutagenesis 
of chromosomal DNA this way is 
cumbersome. The region studied has to be 
cloned in a vector, limiting its size, and even 
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then replacing the original DNA segment 
with a mutagenised allele usually relies 
on comparatively ineffi cient homological 
recombination and subsequent screening 
for mutants. Preparing transpososome 
complexes in vitro, transferring them 
to target cells and letting transposition 
occur in vivo circumvents these problems 
(Goryshin et al., 2000, Lamberg et al., 
2002). Even though not as controllable 
and effi cient as in vitro reactions, the use 
of preassembled transpososomes enables 
transposition to occur in vivo with no need 
to transfer the reaction products. Unlike 
traditional in vivo methods, transposition 
occurs at a fi xed time point and there is 
no risk of remobilisation (Goryshin et al., 
2000, Lamberg et al., 2002). Preassembled 
transpososomes have been used with Tn5 
(Goryshin et al., 2000, Reznikoff et al., 
2004) and bacteriophage Mu systems 
(Lamberg et al., 2002, Pajunen et al., 
2005).
3.2. Applications of transposition 
technology
Transposons have been exploited as 
research tools since the late 1970s, almost 
as soon as their true nature became evident. 
Bacteriophage Mu was used to induce 
homologous recombination between two 
regions containing inserted elements 
(Casadaban, 1975) and in functional gene 
analysis using a derivative transposon 
containing a promoterless reporter gene 
(Casadaban and Cohen, 1979). The study 
of eukaryotes with transposable elements 
started with the P element in Drosophila 
(Spradling and Rubin, 1982). Methods 
based on in vivo transposition of several 
transposons and transposon derivatives 
have been used in identifi cation, mapping, 
regulation and sequencing of genes in 
prokaryotes and eukaryotes (reviewed in 
Berg and Berg, 1995, Kaiser et al., 1995).
3.3. Functional genomics applications
Functional genetics studies the function 
of genes, their parts, and their products 
(RNA, proteins) trying to elucidate their 
function and relationships behind these 
functions. Functional genomics expands 
this study to larger regions of DNA, 
even to whole genomes. Traditionally, 
these functional studies are conducted 
by inducing mutations that disrupt gene 
function.
The completion of extensive whole-
genome sequencing projects, conducted on 
prokaryotes, eukaryotes and viruses at an 
increasing rate onwards from mid-1990s, 
has yielded a massive amount of sequence 
data. However, the functions of  most 
putative genes and other genetic elements 
remain elusive. Transposable elements, 
with their ability to insert into a wide 
range of locations on a DNA molecule, are 
a powerful mutagenising agent that has 
been widely used to analyse the functions 
of genes and their products (reviewed 
in Berg and Berg, 1995, Kaiser et al., 
1995, Hayes and Hallet, 2000, Hamer et 
al., 2001, Hayes, 2003), as well as entire 
genomes (for example Hutchison et al., 
1999, Wong and Mekalanos, 2000, Hare et 
al., 2001, Gerdes et al., 2002, Gerdes et 
al., 2003, Banh et al., 2005, McCarren and 
Brahamsha, 2005, Glass et al., 2006).
3.3.1. Individual genes
Simple insertional transposon mutagenesis 
is an effective way to disrupt target gene(s) 
with both forward and reverse genetics 
approaches. Transposons have been 
engineered to contain specifi c regulatory 
and reporter sequences to study the function 
of target genes and proteins they encode. 
Transposition can generate random gene 
fusions between gene(s) of interest and a 
reporter gene in the transposon to facilitate 
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the analysis of transcription, translation, 
and cellular location of gene products. In 
addition, transposons with a marker gene 
but lacking an enhancer, a promoter or a 
polyadenylation signal are used to probe 
for those regulatory elements (reviewed in 
Berg and Berg, 1995, Kaiser et al., 1995, 
Boeke, 2002, Hayes, 2003).
In targeted mutagenesis of specifi c 
genes the target gene is mutagenised, 
isolated and subsequently transferred back 
into host cell where it replaces the wild-
type allele by homologous recombination. 
This mutagenesis step can be carried 
out with transposition to, for example, 
generate gene-targeting vectors for mouse 
(Westphal and Leder, 1997).
Transposition has also been used 
to generate different mutant libraries to 
study functional domains of proteins and 
protein-protein interactions. Deletion 
variants of proteins have been produced by 
intramolecular (Ahmed, 1984, Tomcsanyi 
et al., 1990, Morita et al., 1996, York et 
al., 1998) or intermolecular transposition 
(Poussu et al., 2005). In scanning linker 
mutagenesis, the insertion and imprecise 
excision of a transposon leaves only a 
short, in-frame insertion in the target 
site. This produces a library of mutations 
throughout the coding region of the gene 
studied, causing a short random insertion 
in the translated protein. By sampling a 
large amount of such mutants, functional or 
interacting domains of the protein studied 
can be defi ned. A variety of in vivo and in 
vitro scanning linker mutagenesis systems 
have been developed employing different 
transposons (Hallet et al., 1997, Hayes and 
Hallet, 2000, Poussu et al., 2004).
3.3.2. Whole-genome level
Different transposon-based methods have 
been devised to study the essential genes 
needed for growth of an organism, including 
genetic footprinting (Smith et al., 1995, 
Akerley et al., 1998, Wong and Mekalanos, 
2000), signature-tagged mutagenesis 
(Hensel et al., 1995), and microarray-
based techniques (Badarinarayana et 
al., 2001, Sassetti et al., 2001). These 
methods involve simultaneous generation 
of large number of insertion mutants either 
in vivo or in vitro, growing mutagenised 
organism under specifi c conditions and 
screening for mutations that affected 
survival. These global screens have been 
conducted in various bacteria and few 
eukaryotic model organisms (reviewed 
in Judson and Mekalanos, 2000, Hamer 
et al., 2001, Hayes, 2003). Transposon-
based functional genomics of viruses are 
discussed in chapter 3.3.2.5.
3.3.2.1. Genetic footprinting
Genetic footprinting is a transposon-based 
genomic strategy for determining the 
functions of sequenced genes (Figure 4). 
This method, originally devised in vivo in 
yeast with Ty1 retrotransposon (Smith et 
al., 1995), has also been applied to cloned 
genes in vitro with transposons or retroviral 
integrases (Singh et al., 1997, Haapa et al., 
1999a, Rothenberg et al., 2001, Auerbach 
et al., 2003).
The use of genetic footprinting has 
been extended to identify candidate 
essential or important genes of bacteria by 
utilising in vitro mutagenesis of cloned / 
purifi ed genomic DNA or PCR products 
followed by transformation into cells 
and homologous recombination into host 
genomes of naturally competent bacteria 
and subsequent growth selection under 
different conditions. This method is also 
called genomic analysis and mapping with 
in vitro transposition (GAMBIT) (Akerley 
et al., 1998). 
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Figure 4. Genetic footprinting. A large number of clones are mutagenised with transposons to 
generate a mutant bank that is subsequently subjected to selection. Polymerase chain reaction 
(PCR) with one transposon-specifi c (P1) and one target-specifi c (P2) primer is used to determine 
the effects of the mutations under selection. PCR bands corresponding to clones that are not vi-
able under selection are excluded from the selected pool, forming a footprint. AGE = agarose gel 
electrophoresis. (Drawn according to Singh et al., 1997)
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Genetic footprinting allows the use 
of large mutant pools but only a relatively 
small number of genes can be screened 
in each PCR, making global whole-
genome analysis laborious (Sassetti et al., 
2001). Variations of this theme use DNA 
hybridisation and/or direct sequencing 
to determine transposon integration sites 
(Akerley et al., 1998, Reich et al., 1999).
The whole-genome analyses of 
bacteria have been carried out with in vivo 
transposon mutagenesis and subsequent 
analysis of transposon integration sites in 
viable clones in several bacteria including 
Mycoplasma genitalium (Hutchison et al., 
1999, Glass et al., 2006), M. pneumoniae 
(Hutchison et al., 1999), Pseudomonas 
aeruginosa (Wong and Mekalanos, 2000), 
Helicobacter pylori (Jenks et al., 2001), 
and E. coli (Badarinarayana et al., 2001, 
Hare et al., 2001, Gerdes et al., 2002, 
Gerdes et al., 2003).
3.3.2.2. Signature-tagged mutagenesis 
(STM)
Signature-tagged mutagenesis (STM) 
is a transposon-based method that uses 
negative selection to simultaneously 
screen multiple mutants affecting 
virulence of pathogenic organisms (Figure 
5). For STM the pathogen in question has 
to be able to infect its host as a mixed 
population. In addition, only those mutant 
genes that cannot be trans-complemented 
by other virulent strains are expected to be 
identifi ed (Chiang et al., 1999). Signature-
tagged mutagenesis has been used with 
various bacterial and fungal pathogens 
(reviewed in Chiang et al., 1999, Hayes, 
2003). While particularly useful for the 
study of pathogenesis, STM is limited by 
the relatively small size of each mutant 
pool and comprehensive screens are 
laborious (Sassetti et al., 2001).
3.3.2.3. Microarray-based methods
Microarray technology allows convenient 
monitoring of genome-wide gene 
expression patterns (Schena et al., 1995, 
Schena et al., 1996). Microarrays have 
been combined with DNA hybridisation 
of transposon sites to study essential 
genes in Mycobacterium (Sassetti et al., 
2001, Sassetti et al., 2003). This method 
is especially useful for identifying the set 
of genes required for survival in different 
conditions (Sassetti et al., 2001). However, 
the ability to defi ne growth requirements 
for individual genes are limited (Sassetti 
et al., 2003). Microarray technology has 
also been used with genetic footprinting 
to study essential genes in E. coli under 
defi ned growth conditions (Badarinarayana 
et al., 2001).
3.3.2.4. Functional studies in 
eukaryotes
Because of their smaller genomes, easier 
handling, and abundance of functional 
transposon systems, most genome-wide 
mutagenesis experiments have been 
conducted in various bacteria (reviewed 
in Judson and Mekalanos, 2000, Hamer 
et al., 2001, Hayes, 2003). In eukaryotes, 
large genome size and the lack of 
endogenous active transposon systems 
have hindered the use of transposable 
elements in the functional studies. 
Budding yeast (S. cerevisiae) has been the 
subject of functional analysis with several 
methods including genetic footprinting of 
chromosomal regions with Ty1 (Smith et 
al., 1996) and shuttle mutagenesis in E. 
coli with bacterial Tn3 (Ross-Macdonald 
et al., 1999). In vivo transposition 
of preassembled Tn5 transpososome 
complexes into budding yeast has also 
been reported (Goryshin et al., 2000). 
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Figure 5. Signature-tagged mutagenesis (STM). Bacteria (or viruses) are mutagenised with trans-
posons that are tagged with a short unique DNA sequence that permits the identifi cation of indi-
vidual mutants. Mutagenised bacteria are then combined into an input pool that is used to infect 
host. After infection an output pool comprising mutants capable of proliferating in host is col-
lected. Mutants with attenuated virulence are the ones detected in input pool but absent in output 
pool. (Adapted from Hensel et al., 1995)
Genome-wide insertion libraries have also 
been generated with endogenous P element 
and heterologous piggyBac in Drosophila 
(Spradling et al., 1999, Ryder and Russell, 
2003, Bellen et al., 2004), Tc1/mariner 
family in C. elegans (Plasterk et al., 
1999), and transposons belonging to hAT 
and CACTA superfamilies in Arabidopsis, 
maize, and other plants (Martienssen, 1998, 
Parinov and Sundaresan, 2000, Walbot, 
2000). In vertebrates Sleeping Beauty, 
a Tc1/mariner family DNA transposon 
resurrected by comparing inactive elements 
in teleost fi sh (Ivics et al., 1997) has been 
the most widely used TE in functional 
genomics studies (reviewed in Izsvak and 
Ivics, 2004, An and Boeke, 2005, Miskey 
et al., 2005).
3.3.2.5. Viral functional genomics
Virus genomes have traditionally been 
studied by inducing conditional mutations 
gene-by-gene, a tedious process that 
requires complementing cell lines and 
homologous recombination followed by 
several rounds of selection. The use of 
transposon mutagenesis in viral functional 
genetics has long been hampered by the 
lack of suitable host systems. However, 
advances in transposon technology and 
development of whole-genome analysis 
methods also applicable with viruses have 
facilitated the study of transposon-based 
viral functional genomics, examples of 
which are summarised in Table 2. 
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Table 2. Transposon-based functional virus genomics studies 
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herpes simplex 
virus type 1 
HSV-1 150 3 Tn5 vivo short region 
cloned in a 
plasmid,
insertional 
Weber et 
al., 1987
murine
cytomegalo-
virus
MCMV 230 8 Tn1721 vivo complete BAC, 
insertional 
Brune et 
al., 1999 
pseudorabies 
virus
PRV 142 23 Tn5 vivo complete BAC, 
insertional 
Smith and 
Enquist,
1999
murine
cytomegalo-
virus
MCMV 230 3 Tn3 vivo plasmid library, 
insertional 
Zhan et al.,
2000b
human
cytomegalo-
virus AD 169 
HCMV
AD169
230 26 Tn1721 vivo complete BAC, 
insertional 
Hobom et 
al., 2000 
human
immuno-
deficiency 
virus type 1 
HIV-1 9.2 - Mu ends vitro cloned segment, 
footprinting
Laurent et 
al., 2000
potato virus A PVA 9.6 1125 Mu ends vitro cloned BAC, 
footprinting
Kekarainen
et al., 2002  
bacteriophage 
PRD1
PRD1 14.9 130 mini-Mu vitro isolated genome, 
insertional 
II
human
cytomegalo-
virus AD169 
HCMV
AD169
230 413 Tn1721 vivo cloned BAC 
footprinting
Yu et al.,
2003
J-herpesvirus 
68
JHV68 118 53 Tn5 vivo Cloned BAC, 
STM 
Moorman
et al., 2004  
bacteriophage 
ΦYeO3-12
ΦYeO3-
12
39.6 18 mini-Mu vitro isolated genome, 
insertional 
III
J-herpesvirus 
68
JHV68 118 1152 mini-Mu vitro Cloned BAC, 
STM 
Song et al.,
2005
bacteriophage 
PM2
PM2 10.1 101 mini-Mu vitro isolated genome, 
insertional 
IV
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Optimally, both transposition and viral 
replication machineries would be functional 
within the same host cell. Classic reports 
of transposon Tn3 and Tn10 insertions 
into genomes of bacteriophage M13 (Ray 
and Kook, 1978) and λ (Kleckner et al., 
1978), respectively, fi ll these criteria. If 
no such system exists, the viral genome 
or parts thereof could be cloned on a 
vector capable of replicating in E. coli 
and subsequent in vivo transpositional 
mutagenesis conducted with one of the 
well-characterised bacterial transposons. 
Parts of herpes simplex virus type 1 (HSV-
1) cloned in a plasmid were mutagenised 
with bacteriophage Mu and transferred 
into viral genome by homologous 
recombination (Jenkins et al., 1985). 
Similar technique was used with Tn5 to 
conduct an assessment of nonessential 
genes in a short region of HSV-1 genome 
(Weber et al., 1987). Low effi ciency 
of transposition, multiple cloning steps 
required, and a laborious screening 
process limit the applicability of this 
method. Nevertheless, Tn3 mutagenesis 
of randomly digested genomic fragments 
of murine cytomegalovirus permitted 
the analysis in viral genomic level and 
facilitated concomitant studies on several 
gene loci, (Lee et al., 2000, Xiao et al., 
2000, Zhan et al., 2000a, Zhan et al., 
2000b, Abenes et al., 2004).
The cloning of virus genomes in an 
infective form in a plasmid, cosmid, or 
bacterial artifi cial chromosome (BAC) that 
is able to replicate in E. coli has enabled 
in vivo transposon mutagenesis of entire 
viral genomes. Such strategies, employing 
different transposons, have been used 
to identify genes essential for virus 
propagation in several cytomegaloviruses 
(Brune et al., 1999, Smith and Enquist, 
1999, Hobom et al., 2000, Yu et al., 2003). 
Moreover, the generation of large mutant 
banks allow whole-genome analyses using 
methods like genetic footprinting and 
signature-tagged mutagenesis.
Besides the analysis of viral proteins 
(Rothenberg et al., 2001, Auerbach et al., 
2003), genetic footprinting has been used 
in viral genome-level studies. Parts and 
entire cloned viral genomes have been 
mutagenised in vitro with transposons 
to study genes essential to viral life 
cycles. A genomic segment of human 
immunodefi ciency virus 1 (HIV) (Laurent 
et al., 2000) and the whole genome of 
Potato virus A (PVA) (Kekarainen et al., 
2002) were mutagenised in vitro with short 
bacteriophage Mu ends, transferred to host 
for propagation and analysed with genetic 
footprinting.
Signature-tagged mutagenesis, 
originally developed for the identifi cation 
of bacterial virulence genes, has also been 
used in vivo (Moorman et al., 2004) and in 
vitro (Song et al., 2005) to simultaneously 
identify multiple genes essential for 
replication of murine gammaherpesvirus 
68.
3.4. Applications of Mu in vitro 
transposition
The minimal Mu in vitro reaction allows 
the transposition of almost any marker 
element(s) surrounded by Mu end DNA 
sequences into whatever target DNA 
deemed convenient enough to handle 
after insertional mutagenesis (Savilahti 
et al., 1995, Haapa et al., 1999a). Mu 
in vitro transposition reaction is highly 
effi cient and has relatively low target 
site selectivity (Mizuuchi and Mizuuchi, 
1993, Haapa et al., 1999a, Butterfi eld et 
al., 2002, Haapa-Paananen et al., 2002). In 
addition, it is possible to have an effi cient 
reaction with Mu ends that are modifi ed to 
contain restriction enzyme cutting sites or 
translational stop codons (Laurent et al., 
2000, article II, Poussu et al., 2005) further 
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broadening the scope of target sequence 
manipulation. These properties make Mu 
in vitro reaction useful for generating 
comprehensive libraries of mutant DNA 
molecules that have been utilised in a 
variety of molecular biology applications. 
DNA sequencing was the fi rst Mu in 
vitro application developed. This simple 
method is based on random transposon 
insertions throughout the target and 
subsequent sequencing to both directions 
using a pair of transposon-specifi c primers 
(Haapa et al., 1999b). Because its effi ciency 
and near-randomness of integration, this 
method has also been applied to high-
throughput sequencing of cDNA clones 
using pools of different targets (Butterfi eld 
et al., 2002). 
Mu in vitro transposition has been used 
to study functional domains of proteins 
and protein-protein interactions with 
scanning linker mutagenesis. A transposon 
with modifi ed Mu ends allows the bulk of 
the transposon to be removed after random 
transposon integration, leaving only a 15-
bp insert. By sampling a large amount of 
such mutants, functional or interacting 
domains of the protein studied can be 
defi ned (Taira et al., 1999, Poussu et al., 
2004). Similarly, a nested set of N-terminal 
deletions can be prepared if, in addition to 
the restriction sites in transposon ends, 
similar restriction site is situated in the 
vector at the start of the coding region. 
A random transposon integration and 
subsequent removal of the transposon and 
the intervening 5’ part of the coding region 
produces a set of mutations with N-terminal 
deletions of different sizes. Generating a 
nested set of C-terminal mutations is even 
simpler: another modifi ed-end transposon, 
with stop codons in all three reading 
frames, is randomly inserted in the coding 
region, producing a set of mutations with 
C-terminal deletions of different sizes. N- 
and C-terminal deletion libraries can be 
used to study functions of protein domains 
(Poussu et al., 2005).
The function of genes, larger regions 
of genomic DNA/RNA, and even entire 
genomes can also be studied using Mu in 
vitro transposition. After random insertion 
of transposons the target DNA is transferred 
into host cells where it can propagate 
and then be subjected to selection. The 
principle of this genetic analysis was 
tested using plasmid pBC SK+. After the 
plasmid was insertionally mutagenised 
it was transformed into E. coli host cells 
and subjected to plasmid replication. The 
mutants having an insertion in the plasmid 
origin of replication, present in the 
unselected mutant pool, were absent in the 
pool of mutants that underwent selection 
(Haapa et al., 1999a). 
Mu in vitro transposition can also 
be used to determine whether a viral 
genomic region is cis-acting or can be 
complemented in trans from another 
molecule. A 1000-nucleotide 5’ end 
segment of human immunodefi ciency virus 
(HIV1) RNA genome was cloned as DNA 
and subjected to insertional mutagenesis. 
After the removal of transposon ends a 
library of 15-bp insertion mutants was 
generated. This mutation library was 
transfected into producer cells and the 
survival of cotransfected mutant virions 
having a defective 5’ end was monitored 
through different stages of the viral life 
cycle. Regions with cis-acting functions 
in a specifi c stage of the life cycle do 
not have transposon insertions in viruses 
that underwent that stage (Laurent et al., 
2000).
It is even possible to perform a 
functional analysis of an entire viral 
genome with Mu in vitro transposition. 
The whole RNA genome of Potato virus 
A (PVA), cloned into a dsDNA vector, was 
subjected to transpositional mutagenesis 
to generate a library of 15-bp insertion 
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mutants. These dsDNA mutants were 
transfected into tobacco protoplasts, where 
they are capable of initiating infection. 
After two days of virus propagation the 
viruses were collected and the transposon 
insertion sites analysed. Genomic regions 
that did not tolerate transposon insertions 
were deemed essential (Kekarainen et al., 
2002).
The use of Mu in vitro transposition 
in functional genetics of mouse and 
whole-genome analysis of bacteriophages, 
the subject of this thesis, is described in 
sections C through E.
4.  EXAMPLES OF MODEL ORGANISMS 
FOR FUNCTIONAL GENETICS AND 
GENOMICS
4.1. Mouse
Mouse (Mus musculus) has historically 
been the most widely used model organism 
in mammal genetics and cell biology, 
primarily due to its physiological similarity 
to man, relatively short generation time, 
and prolifi c offspring production. Even 
though the 2.6 Gb mouse genome is 14 
% smaller than its human counterpart, the 
number of protein-coding genes appears to 
be similar (~30000) and approximately 80 
% of mouse genes have a single identifi able 
human ortholog. The proportion of mouse 
genes that have no detectable human 
homologue appears to be less than 1 % 
(Waterston et al., 2002, updated in Gibbs 
et al., 2004).
The development of powerful 
genome manipulation techniques has 
further emphasised the role of mouse as a 
model organism. Mouse embryonic stem 
cells (ES cells) offer an effi cient means for 
mouse genomic alteration, especially gene 
targeting, systematic alteration of genome 
by homologous recombination (Thomas 
and Capecchi, 1987). Mouse ES cells can 
retain their pluripotency while cultured in 
vitro (Evans and Kaufman, 1981). If these 
cells are reintroduced into mouse blastocyst 
they can contribute to all the cell lines of 
the resulting chimeras, including the germ 
line (Bradley et al., 1984, Thompson et 
al., 1989). Mice that are homozygous for 
the altered allele are obtained by cross-
breeding the offspring of these chimeras. 
It is also possible to completely derive a 
mouse from manipulated, cultured ES cells 
by using developmentally compromised 
tetraploid embryos (Nagy et al., 1993). 
Today, transgenic mice models are pivotal 
in the study of mammalian biology and 
human disease (for reviews see Rossant 
and McKerlie, 2001, Sands, 2003).
4.2. Bacteriophages
4.2.1. PRD1
PRD1 belongs to Tectiviridae, a group of 
icosahedral bacteriophages containing an 
internal membrane. It is a lytic, broad-
host-range virus that infects a variety of 
Gram-negative host bacteria harbouring 
a conjugative N-, P-, or W-type plasmid, 
including Escherichia coli and Salmonella 
typhimurium (Olsen et al., 1974). The 
PRD1 genome is a linear, 14927 bp long 
double-stranded (ds) DNA molecule with 
covalently linked terminal proteins at the 
5’ ends of genomic DNA (Bamford et 
al., 1983, Bamford et al., 1991, Saren et 
al., 2005). The organization of the PRD1 
genome at the transcriptional level is 
relatively well known; there are 49 open 
reading frames (ORFs) divided into two 
early (OE1-2) and three late (OL1-3) 
operons (Grahn et al., 1994, Bamford 
et al., 2002). Because of its physical 
characteristics and broad host-range PRD1 
has been a model organism for biological 
membranes, genomic organisation, and 
recently also structural studies.
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4.2.2. ΦYeO3-12
ΦYeO3-12 belongs to Podoviridae, a 
group of icosahedral, short-tailed dsDNA 
bacteriophages (Ackermann et al., 1997). 
It is a lytic, narrow-host-range virus 
that infects only Yersinia enterocolitica 
serotype O:3 strains (al-Hendy et al., 1991); 
yet, it is closely related to Escherichia 
coli bacteriophages T3 and T7 (Pajunen 
et al., 2000). The genome of ΦYeO3-12 
is a linear, 39600 bp long double-
stranded DNA molecule that harbours 54 
putative genes, all transcribed from the 
same DNA strand and divided to early, 
middle, and late regions (Pajunen et al., 
2001). Y. enterocolitica, a Gram-negative 
bacterium that belongs to the family 
Enterobacteriaceae, is a major source of 
food-borne diseases. The virus-specifi c 
serotype O:3 is, along with O:9, one of the 
two most common pathogenic serotypes in 
Europe, Canada, Japan, and South Africa 
(Bottone, 1997). ΦYeO3-12 was isolated 
from the city sewage of Turku, Finland in 
the late 1980s (al-Hendy et al., 1991). O:3 
serotype specifi city makes it a potential 
biotechnological tool; thus, it was the fi rst 
yersiniophage characterised at molecular 
level (Pajunen et al., 2001).
4.2.3. PM2
PM2 is the only characterised member of 
Corticoviridae, containing an icosahedral 
particle, an internal lipid bilayer, and 
a highly supercoiled circular dsDNA 
genome. It was the fi rst detected lipid-
containing virus when it was isolated off the 
coast of Chile in 1968 (Espejo and Canelo, 
1968b). It is a narrow-host-range lytic 
bacteriophage that infects Gram-negative 
marine bacterium Pseudoalteromonas 
espejiana strain BAL-31 (Espejo and 
Canelo, 1968a, Chan et al., 1978, Gauthier 
et al., 1995) and Pseudoalteromonas sp. 
ER72M2 (Kivelä et al., 1999). The  genome 
of PM2 is a circular, 10097 bp long dsDNA 
molecule harbouring 21 putative genes 
(Männistö et al., 1999) that are organised 
into three operons: two early (OEL and 
OER) and one late (OL)(Männistö et al., 
2003). The PM2 genome has the highest 
reported number of negative supercoils 
in a natural DNA molecule (Gray et al., 
1971). Because of its internal membrane 
PM2 has been the subject of studies on 
the membrane structure and biosynthesis. 
Additionally, its small, circular, and highly 
supercoiled genome has been of interest in 
the DNA topology studies.
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C. AIMS OF THE STUDY
The aim of this project was to study the possibilities to expand the use of Mu in vitro 
transposition in functional genetics and genomics.
1. To prove that this methodology can be used in the functional genetics of higher 
eukaryotes by generating a rapid method for the construction of mouse gene 
targeting vectors essential in the production of transgenic mice.
2. To design a method for the whole-genome functional analysis of bacteriophages 
that have infective genomes and provide means for subsequent modifi cation of 
those genomes.
3. To demonstrate that the whole-genome analysis method developed is applicable 
to bacteriophages infecting different hosts and can also be used to modify viruses 
that have been diffi cult to modify using traditional methods.
4. To further refi ne the method developed and to develop an effi cient mutant 
selection scheme that is not dependent on properties of the organism studied or 
its host. 
Aims of the Study
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D. MATERIALS AND METHODS
The transposon donor DNA fragments and bacteriophages are described in detail in 
the original publications and summarised in Tables 3 and 4, respectively. The bacterial 
strains and plasmids used as well as the bacteriophage mutants generated in this study 
are described in the original publications. The experimental methods used in this study 
are described in the original publications and summarised in Table 5. References for 
published methods can be found in the articles.
Materials and Methods
Transposon Marker feature Length (bp) Reference 
SupF-Mu amber suppressor 370 Haapa et al., 1999a 
LacZ’-Mu lacZ’ α fragment 460 II 
LacZ’-Mu(NotI) lacZ’ α fragment 460 II, III, IV 
Neoflox-Mu neomycin resistance 1418 I 
Bacteriophage genotype Reference 
PRD1 wt Olsen et al., 1974 
ΦYeO3-12 wt al-Hendy et al., 1991 
PM2 wt Espejo and Canelo, 1968b 
Table 3. Transposon donors used in this study
Table 4. Bacteriophages used in this study
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Materials and Methods
Method Described and used in 
3D matrix screening I    
autoradiography  II   
blue/white screening  II III  
Cre/loxP recombination test I    
DNA sequencing and sequence analysis I II III IV 
electroporation I II III IV 
fitness analysis   III  
generation of transgenic mice I    
HPLC I II III IV 
in vitro transposition reactions I II III IV 
in-gel DNA restriction    IV 
luminescence assay   III  
mRNA analysis   III  
PCR I II III  
phage growth and purification  II III IV 
plaque hybridization  II   
plasmid DNA isolation I II III IV 
restriction analysis I II  IV 
self-ligation    IV 
Southern blotting I    
standard molecular cloning techniques I II III IV 
viral DNA isolation  II III IV 
Western blotting I    
Table 5. Methods used in this study
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E. RESULTS AND DISCUSSION
1. CONSTRUCTION OF NOVEL 
MINI-MU TRANSPOSONS (I, II)
In the minimal Mu in vitro reaction 
(Savilahti et al., 1995, Haapa et al., 
1999a), 50-bp fragments derived from the 
right end of bacteriophage Mu that contain 
R1 and R2 transposase binding sites are 
used as transposon donors. Artifi cial 
mini-Mu transposons contain these Mu 
end sequences at their termini in inverted-
repeat orientation. Marker element(s) can 
be placed between these Mu ends in order 
to exploit mini-Mu transposons in various 
applications. Moreover, it is possible 
to modify the transposon end sequence 
somewhat without critically losing 
effi ciency (Laurent et al., 2000, Poussu et 
al., 2005, see below).
For this study, three novel mini-Mu 
transposons were constructed by placing 
a marker sequence between two Mu 
ends in proper orientation. The 1418-bp 
Neofl ox-Mu (Figure 2A in I) contains a 
neomycin phospotransferase (neo) gene, 
allowing selection in mouse ES cells 
(Thomas and Capecchi, 1987). Two loxP 
sites fl ank the marker gene, allowing its 
removal by site-specifi c recombination 
in cells expressing Cre recombinase from 
yeast (Sauer, 1998). 
The 460-bp LacZ’-Mu (Figure 2A in 
II) contains the gene segment coding for 
the α fragment of E. coli β-galactosidase. 
The 460-bp LacZ’-Mu(NotI) transposon 
(Figure 2A in II) was generated from 
LacZ’-Mu by modifying the Mu end 
sequence to contain a NotI restriction 
site that partially overlaps R1 binding 
site (Figure 2B in II). Additionally, we 
used the 370-bp SupF-Mu that contains 
the supF amber suppressor tRNA gene 
from E. coli under its own promoter and 
has been described previously (Haapa et 
al., 1999a; see Figure 2A in II). supF and 
lacZ’ genes were selected as markers due 
to their small size and potential usefulness 
in gene expression analysis. The NotI sites 
of LacZ’-Mu(NotI) enable the removal 
of the marker gene entirely, leaving only 
a 15-bp insertion in the site of integration 
and allow further modifi cation of viral 
genomes by traditional restriction-and-
ligation -based methods. 
Mini-Mu transposons were used in 
linear pre-cut form that ensures effi cient in 
vitro assembly of stable transpososomes, 
a critical prerequisite of transposition 
(Craigie and Mizuuchi, 1987, (Savilahti et 
al., 1995, Haapa et al., 1999a).
The length of an intervening 
sequence between two Mu ends can be 
altered considerably. As the shortest 
mini-Mu transposon described, the 370-
bp SupF-Mu transposes effi ciently. The 
upper limit for the length of a mini-Mu 
transposon has not been defi ned; a 6.8-kb 
transposon functions effi ciently (Lamberg 
et al., 2002), but much longer constructs 
would probably be functional considering 
that the bacteriophage Mu genome is ~37 
kb. However, several binding sites not 
present on mini-Mu transposons assist the 
assembly of native transpososome (see 
chapter 2.2.1. in Introduction). 
2. GENERATION OF MUTANT BANKS 
WITH TRANSPOSITION
In an in vitro transposition reaction the 
MuA transposase catalyses an effi cient 
two-ended integration of linear mini-Mu 
transposons into target DNA at essentially 
random locations (Haapa et al., 1999a). 
This is a highly effi cient method of 
generating a large pool of insertion mutants 
having a random transposon insertion at 
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different locations on the target molecule. 
We performed such reactions on 
A) linear 6688-bp fragment from the 
mouse KCC2 locus (I) 
B)  linear 14927-bp dsDNA genome 
of bacteriophage PRD1 containing 
terminal proteins (II)
C)  linear 39600-bp dsDNA genome of 
bacteriophage ΦYeO3-12 (III)
D)  circular 10079-bp dsDNA genome of 
bacteriophage PM2 (IV)
The progression of reactions was monitored 
by collecting samples from different time 
points and analysing them in agarose gel 
electrophoresis (AGE). The resolution of 
transposition components, products, and 
by-products depends on comparative sizes 
of donor and target molecules as well as 
the absolute size and type (linear / circular) 
of target molecules. The transposons and 
reaction conditions used resulted in an 
effi cient transposition reaction yielding 
mostly target molecules hit by a single 
transposon. Owing to the unspecifi c nature 
of in vitro transposition, some by-products 
(transposons hit by transposons, targets 
hit by multiple transposons) were also 
generated.
2.1. End-modifi ed transposons enable 
further modifi cations of target (II, III)
While modifi ed transposon ends 
containing a NotI restriction site have been 
used previously in reactions employing 
separate Mu ends (Laurent et al., 2000, 
Kekarainen et al., 2002), the impact of 
end-modifi cation on two-ended mini-Mu 
transposons had not been tested previously. 
The transposition of end-modifi ed 
LacZ’-Mu(NotI) progressed somewhat 
slower than with LacZ’-Mu (Figures 3A 
and 3B in II). However, this difference 
could be overcome by simply increasing 
the incubation time. These results indicate 
that end-modifi ed mini-Mu transposons 
can be used to generate a large pool of 
insertion mutants. 
After transposon integration, target 
molecules can be further modifi ed. As 
the sequence between transposon ends is 
inconsequential to transposition, novel 
restriction sites can easily be added to 
mini-Mu transposons to allow post-
integration modifi cations. However, 
in order to remove the bulk of the 
transposon, the Mu ends themselves must 
be modifi ed.  
Because each clone has a unique 
insertion site, a collection of such clones is 
a valuable source for further manipulation 
of the target genomes. This is especially 
useful with bacterial viruses as many 
bacteriophages are notably devoid of 
useful restriction sites. As an eight-cutter 
that has a restriction site on average every 
65536 base pairs in a random double-
stranded sequence, NotI is particularly 
useful in this regard. Novel NotI sites 
introduced to the ΦYeO3-12 genome by 
LacZ’-Mu(NotI) integration were used to 
generate four deletion mutants that were 
analysed to compare the effects of insertion 
and deletion mutations on same genes (II). 
Moreover, if the bulk of the transposon 
can be removed from the integration site, 
the impact of a transposon insertion can be 
minimised, allowing functional analysis 
on a much fi ner level (Hallet et al., 1997, 
Hayes and Hallet, 2000, Laurent et al., 
2000, Kekarainen et al., 2002, Poussu et 
al., 2004).
3. GENERATION OF MOUSE GENE-
TARGETING VECTORS (I) 
Gene targeting into mammalian genomes 
by means of homologous recombination 
is a powerful technique for analysing 
gene function through disruption of genes 
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of interest and subsequent generation of 
transgenic animals. This technique was 
fi rst applied on and has been most widely 
used with mouse ES cells (Thomas and 
Capecchi, 1987, Capecchi, 1989, Nagy 
and Rossant, 1996, Capecchi, 2001). The 
gene-targeting vector generally contains 
a selection marker fl anked by two 
homology arms. Traditionally standard 
molecular cloning techniques involving 
multiple cloning steps and employing 
unique restriction sites have been used in 
the construction of such vectors, a time-
consuming and laborious process (Torres 
and Kühn, 1997, Hasty et al., 2001). A 
transposon insertion method based on 
yeast Ty1 element (Westphal and Leder, 
1997) allows quicker generation of gene 
targeting constructs. However, defi ning 
exact locations of transposon integrations 
and screening for suitable constructs 
remain slow and laborious with the 
strategy described.
We developed an easy strategy for 
generating a large pool of gene-targeting 
plasmid constructs and quick screening 
of the constructs desired based on the in 
vitro transposition of bacteriophage Mu. 
To test the strategy we targeted mouse 
KCC2 gene that encodes a neuronal K+/Cl- 
cotransporter involved in the regulation 
of inhibitory neurotransmission in brain 
(Payne et al., 1996, Rivera et al., 1999). 
KCC2 is lacking convenient restriction 
sites (Haapa et al., 1999b), making 
generation of the constructs with standard 
recombinant DNA methods troublesome.
A transposon integration into an exon 
will produce a knock-out construction. 
Alternatively, an integration of neo cassette 
into an intron in the opposite direction 
relative to the target gene can produce a 
hypomorphic allele by reducing target 
gene expression (Meyers et al., 1998, 
Nagy et al., 1998, Partanen et al., 1998). 
The mechanism involved is unclear and it 
is not known whether hypomorphic alleles 
can be produced from all genes. 
A linear target fragment was 
mutagenised with an artifi cial mini-Mu 
transposon Neofl ox (1418 bp) that contains 
a selection marker placed between loxP 
sites. Insertionally mutagenised target 
molecules were separated in AGE, 
isolated, cloned into a plasmid backbone 
and transferred into bacterial cells. When 
plasmids were amplifi ed from randomly-
picked colonies, 19 / 20 included target 
gene segment hit by a transposon, 
proving the effi ciency of mutagenesis and 
separation methods. 
3.1. A three-dimensional matrix is an 
effective way to sample the targeted 
clones 
A total of 343 bacterial clones, each 
containing a plasmid that harbours a 
randomly inserted transposon in the target 
gene were grown and pooled according to 
a three-dimensional matrix system (Zwaal 
et al., 1993, Koes et al., 1995) with seven 
rows, seven columns, and seven blocks 
(Figure 3A in I); making the total number 
of pools 7 + 7 + 7 = 21. Each clone was 
pooled three times: once according to 
rows (Xnn, X = 1…7)), once according 
to columns (nYn, Y = 1…7), and once 
according to blocks (nnZ, Z = 1…7). This 
way, each clone is represented by a unique 
combination of a row, a column, and a block 
(XYZ). Individual clones harbouring a 
transposon at a specifi c site were identifi ed 
by analysing the sizes of PCR products in 
all the pools and detecting which three 
pools contained a specifi c PCR product.
Multi-dimensional matrix systems 
are an effi cient way to reduce the number 
of PCRs required to distinguish unique 
clones. In our system, 343 clones can be 
identifi ed in 21 simultaneous reactions. 
Since exon 4 (147 bp) comprises 2.2 % 
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of the 6688-bp target segment, assuming 
random integration and 100 % transposition 
accuracy, the probability that in none of 
the 343 clones the transposon integration 
site would reside within exon 4 is almost 
negligible (0.978343 ≈  0.05 % ). 
To confi rm the effi ciency and 
reproducibility of our selection method, 
two sets of clones were pooled in the 
same manner and a clone harbouring a 
transposon close to the 5´ end in exon 4 
of KCC2 was singled out (Figure 3C in 
I and not shown) from each pool. Third 
mutant, harbouring a transposon in intron 
3 was identifi ed for the construction of a 
potentially hypomorphic allele.
Obviously, PCR screens can 
also be performed on single clones. 
However, if multiple integrants are to 
be screened, pooling systems are most 
likely less laborious, especially if the 
targeted region(s) comprise only a small 
proportion of the target molecule. The 
three-dimensional matrix system has 
been previously used to detect rare in vivo 
transposon insertions into defi ned target 
regions (Zwaal et al., 1993, Koes et al., 
1995). Our results indicate that it is also 
very useful and reproducible method to 
screen multiple plasmid constructions in 
one set of simultaneous reactions.
3.2. A variety of different mutants can 
be screened and further generated
The Mu in vitro insertional mutagenesis 
strategy described yields a mutant bank in 
which each clone harbours a transposon 
at a unique location and integration sites 
are spread randomly throughout the target 
molecule. With three-dimensional matrix 
a variety of mutants that have different 
regions disrupted by a transposon can be 
screened. 
In addition to two regular knock-out 
constructs, one potentially hypomorphic 
mutant was picked up and the subsequent 
Western blot analysis of a homozygous 
mouse brain tissue revealed substantially 
reduced KCC2 protein levels (Figure 5 
in I), confi rming that the allele produced 
was hypomorphic. In a follow-up study, 
hypomorphic mice produced using our 
constructs displayed several behavioural 
phenotypes including increased anxiety-
like behaviour and seizure susceptibility, 
having potential implications for human 
neuropsychiatric disorders such as epilepsy 
and anxiety (Tornberg et al., 2005).
Moreover, conditional allele 
-containing constructs can be generated 
from constructs harbouring a transposon 
in an intron by adding a third loxP site on 
the other side of the exon to be removed. 
This can be done with a loxP-containing 
transposon, or with a Neofl ox transposon 
followed by removal of selection cassette 
and another transposition with Neofl ox 
transposon, or by cloning a loxP site using 
traditional restriction-and-ligation -based 
methods (Figure 6 in I).
4. THE WHOLE-GENOME ANALYSIS OF 
BACTERIOPHAGES (II, III, IV)
To date, the use of in vivo transposon 
mutagenesis in the functional analysis 
of viruses has been diffi cult due to the 
incompatibility between transposition 
and viral replication machineries. The 
cloning of viral genomes in infective form 
in plasmids, cosmids, or BACs has been 
used with in vivo transposon mutagenesis 
and whole-genome analysis of various 
cytomegaloviruses (Brune et al., 1999, 
Smith and Enquist, 1999, Hobom et al., 
2000, Yu et al., 2003). In vitro transposition, 
generally more effi cient than reactions 
in vivo, has also been used previously to 
mutagenise complete or partial genomes 
cloned in a suitable vector (Laurent et 
al., 2000, Kekarainen et al., 2002). These 
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methods, while effective if conducted on a 
suitable target, are not applicable to those 
viral genomes that, for example, contain 
terminal proteins that prohibit cloning into 
a standard vector (e.g. PRD1). Moreover, 
vector sequences attached to cloned 
genomes might make it diffi cult to analyse 
correlations between functions disrupted 
and phenotypes observed (Zhan et al., 
2000b).
We utilised bacteriophage Mu in 
vitro transposition to develop an effi cient 
strategy for the whole-genome analysis 
of bacteriophages by mutagenesis. The 
method developed is rapid, effi cient, and 
does not require the genome to be cloned. 
It is also directly applicable to all DNA 
and RNA viruses that have infective 
genomes in the form of DNA, whether 
cloned or uncloned. In our strategy, 
infective viral genomes are mutagenised 
in vitro to generate a large mutant pool 
that is subsequently transferred to host 
cells plated on suitable bacterial growth 
plates. Resulting mutant virus progeny are 
identifi ed and transposon integration sites 
determined to assess genomic regions 
essential or nonessential for the viral life 
cycle. 
4.1. Some mutagenised viral genomes 
remain infective (II, III, IV)
All the bacteriophage species in this study 
– PRD1 (Lyra et al., 1991), ΦYeO3-12 (S. 
Kiljunen and M. Skurnik, unpublished), 
and PM2 (van der Schans et al., 1971, 
Kivelä et al., 2004) – have infective 
genomes. In other words, the transfer of 
viral genome into the host cytoplasm 
is suffi cient to initiate productive 
infection. The viral genomes insertionally 
mutagenised in an in vitro transposition 
reaction were transferred to host cells by 
electroporation (II, III, IV). Incubation 
with host bacteria yielded plaques on 
growth plates using all three viruses (II, 
III, IV), reiterating the fact that these viral 
genomes are infective.
Mutant plaques were screened from 
growth plates by autoradiography (II) 
or visual inspection using blue/white 
screening (II, III). With PM2, mutant 
genomes were isolated in agarose gel 
electrophoresis prior to electroporation, 
yielding almost exclusively mutant 
plaques (IV).
The growth of wild-type-like plaques 
carrying a transposon proved that it 
is feasible to integrate a Mu-derived 
transposon into the viral genomes of 
all the bacteriophages studied with no 
evident effects on the viral life cycle. 
These results demonstrate that within 
the context of a bacteriophage genome, 
gapped and single-stranded transposition 
intermediates are repaired in host cells 
following electroporation. However, it is 
not known whether this repair is done by 
host- or virus-encoded factors. 
Furthermore, the results indicate 
that it is possible to introduce at least an 
additional 460 bp of DNA into genomes 
of all the bacteriophages studied without 
affecting genome packaging into viral 
particles, indicating that all the available 
space in the virus particle is not taken 
up by the wild-type genome. This is 
consistent with previous experiments 
where additional 393 bp was inserted into 
the PRD1 genome by more traditional 
methods (Bamford and Bamford, 2000). 
With ΦYeO3-12 we detected one clone 
that had two separate LacZ’-Mu(NotI) 
integrations, demonstrating that an 
additional 920 bp can be packaged into 
ΦYeO3-12  virus particles. 
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4.2. Mutant bacteriophages can be 
rapidly identifi ed with blue/white 
screening (II, III)
Mutant plaques can be identifi ed from 
growth plates by autoradiography (II). 
However, for rapid visual screening of 
mutants we developed a system based on 
the blue/white screening method (Messing 
et al., 1977, Vieira and Messing, 1982).
Transposons LacZ’-Mu and 
LacZ’-Mu(NotI) contain promoterless 
lacZ’ gene that produces colour on indicator 
plates if the transposon integrates in a 
proper orientation into a genomic region 
that is under a functional promoter. PRD1 
and ΦYeO3-12 genomes mutagenised 
with LacZ’-Mu / LacZ’-Mu(NotI) some 
plaques displayed distinctive blue colour 
either at or around them (Table 2 in II, 
Figure 5 in III) proving that blue/white 
screening is a rapid and effective method 
to screen mutant bacteriophages. By 
comparing the distribution and orientation 
of transposons in clones forming blue 
and colourless plaques it is possible to 
draw conclusions on the direction of gene 
expression at transposon integration sites 
(Figure 7 in II). Moreover, the intensity 
of colour varied among virus clones (II, 
III), evidently refl ecting differences in 
the level of gene expression. However, 
colour intensities were not compared in 
our studies.
An initial attempt to use blue/white 
screening using SupF-Mu, PRD1, and 
host strain having an amber mutation of 
lacZ gene failed (II), possibly due to the 
shutdown of host gene expression upon 
bacteriophage infection or inadequate 
timing in the gene expression of the blue/
white system components. Blue/white 
selection with promoter-containing lacZ’ 
transposons was equally unsuccessful, 
implicating that foreign promoter elements 
can negatively infl uence viral gene 
expression (II, data not shown). 
4.3. Circular mutant genomes 
can be separated with agarose gel 
electrophoresis (IV)
Since blue/white screening is not currently 
available in P. espejiana, the host of PM2, 
we set out to separate mutagenised PM2 
genomes from wild-type genomes prior 
to their introduction into the host. The 
wt PM2 genome is circular, superhelical 
dsDNA, naturally occurring in the 
covalently closed circular (ccc) form. 
A transposon insertion into the genome 
results in two single-stranded gaps around 
the transposon. Consequently, target 
superhelicity is lost and the mutagenised 
genome takes the open circular (oc) form. 
These two topological forms can be 
separated in AGE. AGE separation proved 
very effective as 85...95 % of the clones 
obtained contained a transposon insertion 
(IV and data not shown). This method, 
applicable at least to all small circular, 
superhelical genomes, is not dependent on 
any marker gene activity.
 
4.4. Transposon integrations can be 
verifi ed by restriction analysis (II, II, 
IV) 
Viral DNA was isolated from purifi ed 
mutant plaques and subjected to restriction 
analysis (II, III, IV) to determine 1) the 
number of transposons integrated 2) the 
approximate genomic location of such 
integrations, and 3) whether more complex 
genomic rearrangements had occurred. 
In most clones, 145 of 167 mutants 
in PRD1 (II), 14 of 17 mutants in 
ΦYeO3-12 (III), and 99 of 103 mutants 
in PM2 (IV + unpublished data) the 
restriction pattern was consistent with a 
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single transposon integration. In all the 
bacteriophage genomes mutagenised, 
transposon integrations were observed 
on several different restriction fragments, 
indicating that transposons can integrate 
into several locations along the genome. 
Complex rearrangements were observed 
with low frequency (< 10 %) in all the 
genomes mutagenised. The most common 
rearrangements were deletions of a short 
genomic region (up to 1560 bp in III), 
probably arising from two transposon 
integrations close to each other and 
subsequent homologous recombination 
between these elements.
4.5. Transposon integration sites shed 
light on essential regions of the genome
Conceptually, there are two ways  to 
identify essential genes or regions of 
the genome, negative and positive 
approaches (Judson and Mekalanos, 
2000). The negative approach (Figure 
6A) identifi es many regions that are not 
essential and presumes that everything 
else is essential. The obvious problem 
with negative approach is that it requires 
a large number of independent mutations 
in order to be reliable and even then 
the essentiality of a given gene is just a 
probability. Contrastingly, the positive 
approach (Figure 6B) identifi es genes that 
are essential by generating a conditional 
mutation and showing that it has a lethal 
phenotype. The problem with this approach 
is that producing conditional phenotypes is 
laborious; it is very inconvenient to try to 
cover the whole genome with the positive 
approach. 
The transposon insertion method 
described in this study takes a funda-
mentally negative approach to identify 
essential and nonessential regions of 
the genome. The number of infective 
bacteriophages decreases gradually and 
substantially in an in vitro transposition 
reaction, indicating that at least a fraction of 
transposon integrations inactivate viruses 
by insertion into the essential regions 
of the genome (Figure 3B in II). Viral 
mutants able to form plaques are collected 
and their transposon integration sites, 
refl ecting nonessential genomic regions, 
are determined by DNA sequencing 
outwards to both directions from the 
transposons used (Figure 2A in II).
4.5.1. Integration sites in infective 
mutagenised genomes are not random 
(II, III, IV)
Sequencing information was collected 
from 130 infective PRD1 mutants (Figures 
6 and 7 in II), 17 infective ΦYeO3-12 
mutants (Figure 1 and Table 2 in III) and 
101 infective PM2 mutants (Figure 2 and 
Table 1 in IV).
Overall, in all the genomes 
mutagenised, the transposon integrations 
observed were concentrated on a few 
genomic regions. In PRD1 (II) the 
integration sites were concentrated mostly 
on the ends of the genome. Genomes 
mutagenised with SupF-Mu (370 bp) and 
LacZ’-Mu / LacZ’-Mu(NotI) (both 460 
bp) displayed similar insertion patterns. 
In PM2 (IV) LacZ’-Mu(NotI) transposon 
integrations concentrated on a few 
regions, namely gene XV and promoter 
region boundaries. As transposition of Mu 
into target sites is near-random (Mizuuchi 
and Mizuuchi, 1993, Butterfi eld et al., 
2002, Haapa-Paananen et al., 2002) and 
most transposon integrations into a coding 
region are expected to inactivate the gene 
in question, the distribution of integrations 
observed in functional viruses refl ects 
the uneven distribution of essential and 
nonessential regions in the genome.
The whole-genome analysis using 
our method is obviously dependent on a 
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Figure 6. Two ways to identify essential genes or regions of the genome. A) The negative ap-
proach identifi es non-essential regions. Global transposon mutagenesis generates a large number 
of mutants that are conducted to selection. Viable mutants are recovered and the transposon in-
tegration sites are identifi ed. Regions where no transposon integrations are detected are assumed 
to be essential. B) The positive approach identifi es essential regions directly. Mutagenesis with 
a transposon containing an inducible promoter into a promoter region of a gene generates condi-
tional mutants dependent on inducer for viability. Transposon integration site is determined, al-
lowing the identifi cation of an essential gene downstream from promoter. (Adapted from Judson 
and Mekalanos, 2000)
suffi cient number of insertion mutants 
collected. In PRD1 98 / 130 mutants were 
situated in unique insertion sites, while 
the remaining 32 mutants mapped to 13 
different positions (Figures 6 and 7 in II). 
With PM2, 82 / 101 insertions located at 
unique positions while remaining 19 were 
situated at 8 different sites (IV). These 
fi gures indicate that our conditions are 
near-saturating. Even though there are 
likely a few undetected genomic sites that 
can tolerate a transposon integration, it is 
probable that all the major nonessential 
regions have been detected in our 
analysis.
In the case of ΦYeO3-12 (III) the 
total number of mutants is too low to draw 
conclusions on essential regions of the 
genome, even though it is striking that all 
the integrations are located in the early and 
middle regions of the genome. Moreover, 
ΦYeO3-12 mutants were detected by blue/
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white screening, meaning that they would 
all be within coding regions, thus excluding 
nonessential noncoding regions from 
the analysis. In PRD1 the distribution of 
integration sites of the mutants producing 
blue plaques was noticeably more limited 
than of those producing colourless 
plaques (Figure 7 in II), demonstrating 
the limitations of blue/white screening 
when used as the sole method of detecting 
mutants. 
4.5.2. Genes and ORFs can be divided 
into three classes (II, IV)
According to our analysis of PRD1 and 
PM2 integration sites, the genes and ORFs 
studied can be divided into three classes: 
1) ORFs that do not tolerate transposon 
insertions are most likely protein-coding 
genes that code for a function essential to 
the viral life cycle. However, a transposon 
integration into an upstream location can 
cause disturbances also in the expression 
of downstream genes transcribed from 
the same mRNA. In this regard internal-
promoter-containing SupF-Mu might be 
more destructive than promoterless lacZ’ 
transposons.
In the PRD1 genome most known 
genes did not tolerate transposon 
integrations, including those encoding 
viral DNA polymerase (gene I – Mindich 
et al., 1982, Savilahti et al., 1991), 
major structural capsid protein (gene 
III – Bamford et al., 1983, Bamford and 
Bamford, 1990, Butcher et al., 1995), 
proteins forming the vertex complex (genes 
II, V, and XXXI – Mindich et al., 1982, 
Grahn et al., 1999, Rydman et al., 1999, 
Bamford and Bamford, 2000, Caldentey 
et al., 2000), and many proteins associated 
with the viral membrane (Bamford et al., 
2002).
In the PM2 genome the genes en-
coding major structural proteins under late 
promoter (Kivelä et al., 1999, Huiskonen 
et al., 2004), as well as genes XIII, XIV, 
and XVI encoding repressors and activators 
involved in the switch from early to late 
promoter (Männistö et al., 2003) did not 
tolerate any transposon integrations. ORF 
h was in this class as well, indicating that 
it probably encodes a protein product 
essential to the viral life cycle.
2) ORFs that tolerate insertions but 
apparently only in restricted locations 
are likely to be protein-coding genes the 
product of which is essential for the viral 
life cycle – but the C-terminal part of the 
protein is nonessential. In these cases, a 
truncated, yet still functional, protein was 
expressed (Figure 8 in II, not shown for 
IV).
Known PRD1 genes that tolerated 
some transposon insertions were VIII 
(encoding the genome terminal protein), 
XII (a ssDNA binding protein), and XVII (a 
non-structural assembly factor) while ORF 
t seemed to tolerate insertions only into its 
distal region, indicating that it is likely to 
contain a bona-fi de protein-coding gene. 
ORF t (renamed gene XXXV) has later 
been identifi ed as the gene encoding the 
PRD1 holin (Rydman and Bamford, 2003), 
thereby confi rming our assessment.
In PM2, gene XII (replication initiation 
protein – Männistö et al., 1999) tolerated 
transposon integrations to the distal 3’ 
end of its coding region, indicating that 
the N-terminal part of the protein product 
is essential for function. Gene IX (a 
structural protein believed to be involved 
in genome packaging – Männistö et al., 
1999, Strömsten et al., 2005) tolerated 
only the substitution of its fi nal amino 
acid, indicating that the protein product is 
essential. 
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ORF q of PRD1 as well as ORFs 
b and d of PM2 tolerated a transposon 
integration at a single site, not enough to 
draw conclusions on their essentiality.
3) ORFs that tolerate transposon 
insertions throughout their entire length 
either code for proteins nonessential for 
the viral life cycle in conditions used or 
are phantom ORFs that do not code for a 
protein product.
In PRD1, genome gene XIX (a ssDNA 
binding protein), known to be nonessential 
(Mindich et al., 1982, Pakula et al., 1993), 
tolerated transposons throughout its coding 
region. Moreover, ORFs u and v are at 
most nonessential and, on the basis of the 
lack of colour forming with lacZ’, very 
likely do not code for a protein product.
In PM2, gene XV (repressor of 
early promoters – Männistö et al., 2003) 
unexpectedly appeared to be nonessential 
as it tolerated 39 transposon integrations 
throughout its coding region. ORFs e, k, 
and l also tolerated integrations at multiple 
locations.
Noncoding regions that are 
transposon-intolerant are apparently 
involved with essential virus functions, 
e.g. virus replication, genome packaging, 
or regulation of gene expression. This was 
evident in PRD1 ITRs, where extreme 85 
bp was transposon-intolerant at both ends. 
In PM2, transposon integrations near 
promoter regions clearly affected viral 
gene expression, delaying host cell lysis. In 
ΦYeO3-12, the mutants were exclusively 
detected using blue/white screening 
(III), effectively selecting for coding-
region insertions. Thus, the evaluation of 
noncoding regions was not possible. 
It must be noted that our assessments 
are only valid in the experimental 
conditions used. For instance in the case 
of ΦYeO3-12, several mutations had 
more severe effect on virus fi tness in Y. 
enterocolitica than in E. coli (Table 4 and 
Figure 2 in III).
4.6. Additional experiments can 
complement integration site 
information 
The generation of insertionally 
mutagenised bacteriophage genome 
pools, their subsequent introduction 
into host cells, and the analysis of 
integration sites in viable clones yields 
important information on essential and 
nonessential regions of the whole virus 
genome. Coupled to blue/white screening, 
this method reveals information on the 
direction and potentially also the intensity 
of gene expression along the genome. In 
addition to general genomic information 
directly derived from the integration sites, 
additional experiments can be conducted 
on the mutant viruses generated to obtain 
more specifi c information on the genes 
altered. 
4.6.1. Fitness analysis (III)
Fitness analysis (Rokyta et al., 2002) 
measures the number of doublings of 
infective bacteriophage particles per 
generation. These can be used to determine 
the effect of transposon integration on the 
overall fi tness of virus. To study whether 
the changes caused by transposition 
integration are host-specifi c, viruses 
capable of infecting several host species 
can be analysed using alternative hosts.
4.6.2. Deletion mutants and 
complementation tests (III)
The introduction of rare NotI restriction 
sites enable further genome modifi cations 
with standard molecular cloning 
techniques. The bulk of the transposon can 
be removed, generating a library of short 
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insertions. Alternatively, other control 
elements can be inserted to the integration 
site. 
Deletion mutants are useful in studying 
whether the phenotypes observed are due 
to the disruption of a particular target gene 
or the insertion of the transposon itself. 
Deletion mutants can be generated using 
two clones having transposon integrations 
at nearby sites, digesting genomes with 
NotI and ligating the 5’ part of one clone 
to the 3’ part of the other clone. To study 
whether the function disrupted can be 
complemented in trans, intact target gene 
can be cloned into a plasmid vector and 
transferred into the host cell. This type of 
analysis can also confi rm that the phenotype 
detected is due to the mutation induced 
and not a random mutation elsewhere in 
the genome.
4.6.3. Level of gene expression (III)
Since bacteriophage genes are  poly-
cistronic, i.e. several genes are controlled 
by the same promoter, a phenotype 
observed can result not only from a 
mutation to the gene itself but also due 
to polar effects of mutations further 
upstream in the transcript. To study the 
polar effects of a mutation, an analysis of 
mRNA transcription timing and levels of 
a downstream gene can be studied by RT-
PCR.  
The activity of viral RNA polymerase 
can also be studied in general. In the 
luminescence assay a fi refl y luminescence 
gene is inserted under a bacteriophage-
specifi c promoter in a plasmid that is 
then transferred into a host cell. During 
infection, luminescence levels are 
measured to monitor the activity of the 
bacteriophage RNA polymerase.
4.6.4. One-step growth assay (IV)
With all the bacteriophages mutagenised 
some clones displayed plaque morphol-
ogies deviating from wild-type viruses. In 
PM2 30 clones forming non-wt plaques 
were further analysed in the one-step 
growth assay in which the absorbance of 
host bacteria infected with mutant viruses 
is followed until lysis. This experiment 
yielded information on factors affecting 
virus-induced host cell lysis (IV). 
4.7. The method developed yielded novel 
information on each bacteriophage 
studied
4.7.1. PRD1 (II)
PRD1 was ideally suited to be the 
target with which to develop the in vitro 
transpositional mutagenesis method. Its 
terminal protein -containing (Bamford 
et al., 1983), infective (Lyra et al., 
1991) genome is completely sequenced 
(Bamford et al., 1991) and transcriptional 
organisation has been established (Grahn 
et al., 1994), providing comparative 
data for functional analysis. Moreover, 
the genome is almost totally devoid of 
useful restriction sites, limiting genome 
manipulation with traditional methods.
Experiments with PRD1 (I) proved that 
it is possible to use in vitro transposition 
to study an isolated but uncloned bacterio-
phage genome, even one with terminal 
proteins attached. Furthermore, the analysis 
was possible with multiple transposons 
and blue/white selection proved effi cient. 
The end-modifi ed lacZ’-Mu(NotI), that 
allows further modifi cation with standard 
molecular cloning techniques, was almost 
as effective as unmodifi ed transposons. 
The information obtained on the 
functional organisation of the PRD1 
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genome was in accordance with previous 
studies (Grahn et al., 1994, updated in 
Bamford et al., 2002), further validating 
the method developed. Moreover, the 
mutants generated can be used to analyse 
functions of individual genes and proteins. 
Rydman and Bamford (2003) identifi ed 
ORF t as gene encoding PRD1 holin 
using more traditional methods and also 
analysed the effect of six transposon 
integration mutants generated in our study 
on the holin function.
4.7.2. ΦYeO3-12 (III)
The results on ΦYeO3-12, the second 
bacteriophage mutagenised with mini-Mu 
transposons, proved that the methods 
developed are applicable to bacteriophages 
other than PRD1. 
The emphasis of the analysis of 
ΦYeO3-12 was on the effects of individual 
genes and the possibility of genome 
manipulation. Hence, unlike with PRD1 
and PM2, the amount and type of mutants 
collected is insuffi cient for a true whole-
genome analysis. Nevertheless, the use 
of fi tness, complementation, and gene 
expression analysis on individual mutants 
demonstrated how individual clones 
obtained by large-scale mutagenesis can 
be further analysed individually using 
the positive approach for the assessment 
of essentiality (Judson and Mekalanos, 
2000 and Figure 6). Equally important, the 
deletion mutants generated demonstrate the 
ease of which transposons can be utilised 
to alter the genome of a bacteriophage 
that has been particularly troublesome 
to manipulate using standard molecular 
cloning techniques (S. Kiljunen, personal 
communication).
The results on  ΦYeO3-12  also 
illustrate the limits of whole-genome 
analysis. Based on complementation 
analysis, transposon integrations 
upstream of gene 1 encoding RNA 
polymerase delay its expression and lead 
to reduced bacteriophage fi tness. Thus, 
genes upstream of gene 1 appear more 
important to bacteriophage fi tness with 
transposon analysis than they really are. 
On the other hand, integrations to genes 
1.3 and 3.5 encoding bacteriophage 
ligase and lysozyme, respectively, reduce 
bacteriophage fi tness in Y. enterocolitica 
but not in E. coli, indicating that 
ΦYeO3-12 has adapted to use the former 
as a host and further reinforce the fact that 
the essentiality of a given gene in a study 
applies only to conditions used. While 
the whole-genome mutagenisation gives 
a useful overview of the genome studied, 
functions of individual genes can only be 
reliably assessed with concomitant studies 
focused on individual genes – and in a 
biologically relevant system.
4.7.3. PM2 (IV)
The mutagenisation of PM2 proved that the 
method developed is also applicable to a 
bacteriophage and a host that and are from 
a completely different environment and 
belong to different phylogenetic groups 
than those used previously. Furthermore, 
transpositional mutagenesis was shown to 
be a useful method in a system for which 
no alternative genetic tools are available. 
The gel-electrophoresis -based separation 
method of mutant genomes proved very 
effi cient, generating a pool of almost 
exclusively mutant clones. 
Based on the one-step growth assay 
analysis of the mutants and analogous 
genes present in other viruses, ORFs k 
and l were identifi ed to be involved in 
host cell lysis, suggesting that they form 
a lysis cassette. These genes merit further 
examination. 
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4.8. In PM2 / P. espejiana system not 
all integration sites are repaired in the 
same way (IV)
One of the hallmarks of Mu transposition, 
the 5-bp target site duplication (Allet, 
1979, Kahmann and Kamp, 1979) has 
been evident in Mu in vitro transposition 
applications where transposon products 
are repaired in E. coli, (Haapa et al., 1999a, 
Haapa et al., 1999b, Laurent et al., 2000, 
Haapa-Paananen et al., 2002, Kekarainen 
et al., 2002, Poussu et al., 2004). The same 
pattern was observed in all the mutants 
generated for mouse gene-targeting (I), as 
well as in all the PRD1 (II) and ΦYeO3-12 
(III) mutants apart from those that had 
undergone more complex rearrangements. 
However, in the case of PM2, the 5-bp 
target site duplication was not uniform as 
37 of 99 (37%) mutants had one normal 
transposon / target junction, but retained 
the 4-nt single-stranded transposon fl ank 
in the other end. Seven of these mutants 
had 1-bp target site duplication, while in 
29 mutants the target sequence had no 
duplications or deletions. One mutant 
displayed a one-base-pair deletion.
In Mu transposition the transposon 
/ target junction single-stranded gaps are 
repaired by host DNA replication / repair 
machinery (Kruklitis and Nakai, 1994, 
Nakai and Kruklitis, 1995). In previous 
Mu in vitro applications, the processing 
of the transposition product ends has 
occurred in E. coli. With PM2, its natural 
host P. espejiana was used.  Alternative end 
processing has also been observed in yeast 
using preassembled Mu transpososomes 
as donors (H. Turakainen and H. Savilahti, 
unpublished), indicating that non-E. coli 
hosts might at least occasionally repair the 
transposon ends differently. However, it is 
not entirely impossible that virus-encoded 
factors were involved in the repair of 
transposon / target junctions involving viral 
genomes. This possibility could be studied 
by transferring mutagenised genomes of 
a broad-host-range virus to a variety of 
hosts and detecting the transposon / target 
junction sequences.
4.8.1. A model for the alternative 
processing of transposon ends observed 
in P. espejiana
We present a feasible model for 
alternative processing of transposon / 
target junctions observed with PM2 in 
P. espejiana. Transposition generates 
a transposon / target intermediate that 
contains 5-nucleotide (nt) single-stranded 
regions and 4-nt non-complementary 
overhangs from transposon fl anks. In 
standard processing (Figure 5A in IV) 4-nt 
overhangs are cleaved by a nuclease and 
5-nt single-stranded region is fi lled in by 
a DNA polymerase. The nick is sealed by 
a ligase. Contrastingly, in the alternative 
end processing (Figure 5B in IV) the 5-
nt single-stranded region is cleaved by an 
endonuclease and ensuing DNA ends are 
processed by an exonuclease and a DNA-
polymerase, resulting in blunt ends that 
are joined by a ligase. Within the joint, 
the 4-nt transposon fl ank is retained. This 
model of alternative end processing would 
explain different outcomes observed 
at alternatively-processed ends (1-bp 
duplication / no change in target sequence 
/ 1-bp deletion).
Interestingly, even though this 
alternative processing was relatively 
common (37 % of mutants had one 
alternatively processed end), no mutants 
with two alternatively processed 
transposon ends were detected. If the 
method of end processing is uncoupled 
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from processing at the other transposon 
/ target junction, in a pool of 99 mutants 
one would statistically expect to encounter 
several mutants with two alternatively 
processed ends. Even though the sample 
size is too small to draw any defi nite 
conclusions, this might indicate that the 
end processing of one end restricts the 
processing of the other end. According 
to the model presented, the transposon / 
target bond is temporarily cleaved in the 
alternative processing (Figure 5B in IV). 
Evidently the repair machinery can at 
least occasionally ligate loose ends back 
together at one transposon / target junction, 
indicating that ends might be held together 
in a nucleoprotein complex. However, this 
type of end rescue might be too diffi cult 
if both junctions are cleaved, effectively 
releasing the transposon entirely from the 
target site.
4.8.2. Alternative end processing can 
affect Mu in vitro-based applications
In its natural host, E. coli, Mu transposon 
ends appear to be repaired in uniform 
fashion, making the transpositional 
mutagenesis system practical for a variety 
of applications. Alternative end processing 
is a phenomenon that potentially has 
consequences affecting applications based 
on the Mu in vitro transposition. On one 
hand, the fact that ends are not processed 
in the same way every time provides an 
opportunity to generate slightly different 
mutations on the same site, thus providing 
additional material for functional analysis. 
On the other hand, applications that rely 
on consistent 5-bp target site duplication, 
for example pentapeptide scanning 
mutagenesis (Hallet et al., 1997, Poussu 
et al., 2004), would be disrupted in some 
non-coli hosts. 
Results and Discussion
42
F. CONCLUSIONS AND FUTURE PERSPECTIVES
This study expanded the use of 
bacteriophage Mu in vitro transposition 
methodology in functional genetics and 
genomics by describing novel methods 
applicable to the targeted transgenesis of 
mouse and the whole-genome analysis of 
bacteriophages. The methods described in 
this study are rapid, effi cient, and easily 
applicable to a wide variety of organisms, 
demonstrating the potential of the Mu 
in vitro transposition technology in the 
functional analysis of genes and genomes. 
An easy-to-use, rapid strategy to 
generate constructs needed for targeted 
transgenesis of mouse and to sample desired 
constructs from a large mutant pool was 
developed (I). This method was shown to 
generate a large pool of mutants. Desirable 
mutants with transposon integrated in 
the region of interest were conveniently 
picked up with the PCR-based three-
dimensional matrix screening technique 
adopted. Transpositional mutagenesis 
was also shown to produce potentially 
hypomorphic alleles and one such allele 
was shown to cause a hypomorphic 
phenotype in a transgenic mouse. In 
addition, the constructs generated can 
easily be used to produce conditional alleles 
with an additional round of transposon 
mutagenesis and mutant screening. 
The strategy developed is suitable for 
generating gene-targeting constructs 
of any gene from mouse or any other 
organism for which analogous targeted 
gene disruption techniques based on 
mutagenesis and subsequent homologous 
recombination are used. The hypomorphic 
alleles produced in this study were later 
used to study behavioural phenotypes in 
KCC2-defi cient mice (Tornberg et al., 
2005). Moreover, other selection methods 
could easily be developed for this system. 
Placed under a prokaryotic promoter, 
neomycin phosphotransferase gene 
confers resistance to prokaryotic antibiotic 
kanamycin. If the neo cassette used was 
placed under a dual prokaryotic/eukaryotic 
promoter, this kanamycin selection could 
be used to generate a mutant construct 
pool. More complex mini-Mu transposons 
can also be designed to allow additional 
marker genes and sophisticated selection 
schemes, as was done in a later study 
(Jukkola et al., 2005).
Similarly, an effi cient strategy 
to study the functional organisation 
of bacteriophages was developed. 
Bacteriophage genomes were mutagenised 
with marker transposons and selected for 
their ability to form plaques to distinguish 
regions essential and nonessential for the 
viral life cycle. The strategy was shown 
to function with three bacteriophages 
from different genera and hosts: PRD1 
(II), ΦYeO3-12 (III), and PM2 (IV). 
All three viruses were able to survive 
transposon integration into their genomes, 
demonstrating additional packaging 
capability of their respective capsids. 
Blue/white screening was shown to be an 
effi cient way to screen for mutant viruses 
with E. coli host, providing additional 
information on direction and intensity of 
gene expression at the integration sites. 
Furthermore, mutagenised PM2 genomes 
were effi ciently isolated with agarose 
gel electrophoresis, bypassing the need 
for screening. End-modifi ed transposons 
were shown to be effi cient donors of 
transposition and their capability to further 
modify virus genomes was demonstrated by 
generating deletion mutants of ΦYeO3-12. 
Additional experiments were conducted 
on selected mutants to determine their 
fi tness, growth curves, and/or whether the 
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mutation could be complemented in trans. 
New biological information was gathered 
from all three bacteriophages. Essential 
and nonessential regions of PRD1 and 
PM2 were defi ned, revealing several 
nonessential genes and ORFs. In PRD1 
the essential region of ITRs were also 
defi ned. In PRD1, where information on 
the genomic organisation was available, 
the results were in accordance with 
previous and subsequent studies conducted 
with traditional methods (Grahn et al., 
1994, Bamford et al., 2002, Rydman and 
Bamford, 2003). In ΦYeO3-12 ligase and 
lysozyme genes were identifi ed to function 
host-specifi cally and transposon insertions 
upstream of gene 1 were detected to cause 
growth defects due to delayed expression 
of gene 1. In PM2 lysis-associated genes 
were identifi ed. With PM2, the processing 
of transposon ends was not uniform and 
a feasible model was presented to explain 
this phenomenon. The effect of different 
hosts to end processing could be studied 
by mutagenisation of a broad-host range 
virus and subsequent infection of different 
host bacteria.
Rapid and effi cient Mu in vitro 
transpositional mutagenesis strategy is 
directly applicable to all prokaryotic and 
eukaryotic dsDNA viruses with infective 
genomes. It can equally be applied to 
RNA and ssDNA viruses that can be 
cloned as dsDNA in an infective form 
on a replicon and, using a helper virus, 
probably to most other viruses that do not 
pass aforementioned criteria. Moreover, 
the limits of packageable genome for each 
bacteriophage could easily be studied with 
a set of different-sized transposons. The 
genomes of independent organisms might 
be too large to handle and mutagenise in 
vitro with the strategy developed and the 
sequencing costs to determine integration 
sites in much larger genomes might 
currently prove prohibitive. However, 
it could be worthwhile to test this type 
of mutagenesis with the genomes of 
smallest intracellular parasite bacteria. 
With very large genomes the use of in 
vivo mutagenesis with preassembled 
transpososomes (Goryshin et al., 2000, 
Lamberg et al., 2002) is likely to be the 
method of choice.
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